<SEC-DOCUMENT>0001493152-22-011691.txt : 20220502
<SEC-HEADER>0001493152-22-011691.hdr.sgml : 20220502
<ACCEPTANCE-DATETIME>20220502062016
ACCESSION NUMBER:		0001493152-22-011691
CONFORMED SUBMISSION TYPE:	10-K/A
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220502
DATE AS OF CHANGE:		20220502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NanoVibronix, Inc.
		CENTRAL INDEX KEY:			0001326706
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36445
		FILM NUMBER:		22879273

	BUSINESS ADDRESS:	
		STREET 1:		525 EXECUTIVE BLVD
		CITY:			ELMSFORD
		STATE:			NY
		ZIP:			10523
		BUSINESS PHONE:		(914) 233-3004

	MAIL ADDRESS:	
		STREET 1:		525 EXECUTIVE BLVD
		CITY:			ELMSFORD
		STATE:			NY
		ZIP:			10523

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nano Vibronix, Inc.
		DATE OF NAME CHANGE:	20111206

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nano Vibronix Inc
		DATE OF NAME CHANGE:	20050510
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K/A
<SEQUENCE>1
<FILENAME>form10-ka.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:NAOV="http://nanovibronix.com/20211231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_NAOV_nanovibronix.com_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20210101_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001326706 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_Segment_0_Segment -->
<!-- Field: Set; Name: xdx; ID: xdx_065_ILS_0_Israelinewshekel -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityCentralIndexKey">0001326706</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="naov-20211231.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-01-01to2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326706</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326706</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326706</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Segment">
      <xbrli:measure>NAOV:Segment</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="ILS">
      <xbrli:measure>NAOV:Israelinewshekel</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90E_edei--DocumentType_c20210101__20211231_zr8vXG5hGYz6"><span><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentType">10-K/A</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>(Amendment
No. 1)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span><span id="xdx_90D_edei--DocumentAnnualReport_c20210101__20211231_zIWfmBogAAA3"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></span>
<span style="font-size: 10pt"><b>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the fiscal year ended <span id="xdx_90F_edei--DocumentPeriodEndDate_c20210101__20211231_zjm6ramsKjx9"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><span id="xdx_907_edei--CurrentFiscalYearEndDate_c20210101__20211231_zuDI7alCVr97"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric></span>, <span id="xdx_90E_edei--DocumentFiscalYearFocus_c20210101__20211231_zzE0Mlbrx615"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentFiscalYearFocus">2021</ix:nonNumeric></span></ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span><span id="xdx_90C_edei--DocumentTransitionReport_c20210101__20211231_zMHLYQzsd63g"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></span>
<span style="font-size: 10pt"><b>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the transition period from to</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
File Number: <span id="xdx_90C_edei--EntityFileNumber_c20210101__20211231_ze2AwNRyNgR1"><span><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityFileNumber">001-36445</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_904_edei--EntityRegistrantName_c20210101__20211231_zJ3Fah5AfHvb"><span><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityRegistrantName">NanoVibronix, Inc.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20210101__20211231_zfCv0EmA5bf8"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20210101__20211231_zhY6cZT9COo7"><span><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityTaxIdentificationNumber">01-0801232</ix:nonNumeric></span></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction of</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    Number)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span id="xdx_90D_edei--EntityAddressAddressLine1_c20210101__20211231_zbl79x6Djx26" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine1">525
    Executive Blvd.</ix:nonNumeric></b></span><b> <span id="xdx_90C_edei--EntityAddressCityOrTown_c20210101__20211231_zdukvQIi58S6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressCityOrTown">Elmsford</ix:nonNumeric></span></b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
    <span id="xdx_902_edei--EntityAddressStateOrProvince_c20210101__20211231_zpVjXzfmeq6"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityAddressPostalZipCode_c20210101__20211231_zImk5CMSNXb6" title="Entity Address, Postal Zip Code"><span><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressPostalZipCode">10523</ix:nonNumeric></span></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive office)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span><span><span id="xdx_905_edei--CityAreaCode_c20210101__20211231_zpa04CxcSU2a"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:CityAreaCode">(914)</ix:nonNumeric></span></span> <span id="xdx_903_edei--LocalPhoneNumber_c20210101__20211231_zwwwjEf0tkr"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:LocalPhoneNumber">233-3004</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--Security12bTitle_c20210101__20211231_zzA3SW8NvXkb"><span><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:Security12bTitle">Common stock, par value $0.001 per share</ix:nonNumeric></span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span id="xdx_90A_edei--TradingSymbol_c20210101__20211231_zpjnWWEtJYv" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:TradingSymbol">NAOV</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--SecurityExchangeName_c20210101__20211231_zQHlpTNcvxM5"><span><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span></span>
    Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(g) of the Act: None</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; <span><span id="xdx_900_edei--EntityWellKnownSeasonedIssuer_c20210101__20211231_zUfGcGqfoeA5"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#9744; <span><span id="xdx_902_edei--EntityVoluntaryFilers_c20210101__20211231_zyazFVkn6tW7"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2)
has been subject to such filing requirements for the past 90 days. <span><span id="xdx_908_edei--EntityCurrentReportingStatus_c20210101__20211231_zROvbMfqSREc"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). <span><span id="xdx_90F_edei--EntityInteractiveDataCurrent_c20210101__20211231_zaeZxQyUW2D4"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_908_edei--EntityFilerCategory_c20210101__20211231_zgJQQQv87Fxg"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_90A_edei--EntitySmallBusiness_c20210101__20211231_z9GHJK38uRk7"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20210101__20211231_zZgFZjMJAgu9"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. <span id="xdx_90A_edei--IcfrAuditorAttestationFlag_c20210101__20211231_zMyGPkKHNO7k"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#9744; <span><span><span id="xdx_900_edei--EntityShellCompany_c20210101__20211231_z4gsDtWHRNcj"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span></span></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate market value of our common stock held by non-affiliates as of June 30, 2021, was approximately $<span id="xdx_90B_edei--EntityPublicFloat_iI_pn3n3_c20210630_zEIkDAp6ESa6" title="Entity Public Float"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,447,579</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares outstanding of the registrant&#8217;s Common Stock as of April 29, 2022 was <span id="xdx_907_edei--EntityCommonStockSharesOutstanding_iI_pid_c20220428_zhsacdW6TlUf"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-04-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,997,793</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DOCUMENTS
INCORPORATED BY REFERENCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
    Firm ID</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Auditor
    Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Auditor
    Location</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--AuditorFirmId_c20210101__20211231_zrFJuCAhLJli"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorFirmId">688</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--AuditorName_c20210101__20211231_zaGd0t4EPtal"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorName">Marcum LLP</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--AuditorLocation_c20210101__20211231_zeThNONU9QVf"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorLocation">New York, NY</ix:nonNumeric></span></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="exp_001"></span><span>EXPLANATORY
NOTE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--AmendmentDescription_c20210101__20211231_z7HCnkqoN5ef"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AmendmentDescription">This
Amendment No. 1 to our Annual Report on Form 10-K (this &#8220;Amendment&#8221;) amends the Annual Report on Form 10-K for the fiscal
year ended December 31, 2021 of NanoVibronix, Inc., as originally filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
on April 15, 2022 (the &#8220;Form 10-K&#8221;). We are filing this Amendment to present the information required by Part III of Form
10-K that was previously omitted from the Form 10-K in reliance on General Instruction G(3) to Form 10-K because a definitive proxy statement
containing such information will not be filed within 120 days after the end of the fiscal year covered by the Form 10-K. Accordingly,
the reference on the cover page of the Form 10-K to the incorporation by reference of our definitive proxy statement into Part III of
the Form 10-K has been removed.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Item 15 of Part IV has been amended to include Exhibits 10.61 and 10.62 (certain executive employment agreements), which were
inadvertently omitted from the Form 10-K and new certifications by our principal executive officer and principal financial officer pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002. The certifications of our principal executive officer and principal financial officer
are filed with this Amendment as Exhibits 31.3 and 31.4 hereto. Because no financial statements have been included in this Amendment
and this Amendment does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4 and
5 of the certifications have been omitted. Additionally, we are not including the certificate under Section 906 of the Sarbanes-Oxley
Act of 2002 as no financial statements are being filed with this Amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described above, no other changes have been made to the Form 10-K. Other than the information specifically amended and restated herein,
this Amendment does not reflect events occurring after the date the Form 10-K was filed, or modify or update those disclosures that may
have been affected by subsequent events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PAGE</b>&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#exp_001">EXPLANATORY NOTE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#a_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART III</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors, Executive Officers and Corporate Governance</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Compensation</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">11</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">17</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Relationships and Related Transactions, and Director Independence</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Accountant Fees and Services</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">2<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#b_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART IV</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#b_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits and Financial Statement Schedules</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#a_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signatures</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_001"></span>PART
III</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>ITEM
10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the name, age and positions of each director as of April 29, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 75%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position
    with the Company</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Murphy</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer
    and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harold Jacob, M.D. </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Medical Officer and
    Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher Fashek</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin Goldstein, M.D.
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Ferguson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas R. Mika</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aurora Cassirer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maria Schroeder</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following sets forth biographical information and the qualifications and skills for each director:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Brian
Murphy, Chief Executive Officer and Director</i>.</b> Mr. Murphy has served as our chief executive officer and director since October
2016. Mr. Murphy has over 25 years of senior sales, operations and general management experience in medical device and medical technology
companies, including ATI Medical Equipment Corporation, Mountain Medical Equipment Inc. and Healthdyne Technologies Inc. From 2012 to
2016, Mr. Murphy served in various roles at MiMedx Group, Inc., where he initiated and managed the commercial sales and national accounts
efforts within the advanced wound care segment. From 2010 to 2012, Mr. Murphy was the chief executive officer of O2 Insights, Inc., a
start-up wound care diagnostics company, and led the sale of the company to Systagenix Ltd. in June 2012. From 2008 to 2010, Mr. Murphy
served as vice president of sales for ConvaTec and led the negative pressure wound therapy business. From 1992 to 2008, Mr. Murphy served
a total of 17 years at Kinetic Concepts, Inc. (KCI) in various positions overseeing sales, operations and general management. Mr. Murphy
holds a bachelor of arts degree in communications from Southern Illinois University. Mr. Murphy&#8217;s qualifications to serve on our
Board include his significant sales, operations and general management experience in medical device and medical technology companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Harold
Jacob, M.D., Chief Medical Officer and Director</i>.</b> Dr. Jacob has served as our chief medical officer since March 1, 2014, and as
our director since September 2003. From September 2003 to February 4, 2014, Dr. Jacob served as chairman of our Board and from September
2003 to March 1, 2014, Dr. Jacob served as our chief executive officer. Dr. Jacob also performed the functions of a principal financial
officer until April 1, 2014. Dr. Jacob is our co-founder and has worked extensively in medical device development. Dr. Jacob also served
part-time as an attending gastroenterologist at Shaare Zedek Medical Center in Jerusalem, Israel from 2004 to March 2011. Since April
2011, he has been an attending physician in Gastroenterology at Hadassah University Hospital in Jerusalem, Israel. From 1999 to the present,
Dr. Jacob has served as the president of Medical Instrument Development Inc., which provides consulting services to start-up and early
stage companies and patents its own proprietary medical devices. From 1997 to 2003, Dr. Jacob served as director of medical affairs at
Given Imaging Ltd., a company that developed the first swallowable wireless pill camera for inspection of the intestines. Dr. Jacob also
formerly served as a director for Oramed Pharmaceuticals Inc., a pharmaceutical company focused on the development of innovative orally
ingestible capsule medication. We believe that Dr. Jacob&#8217;s qualifications to serve on our Board include his years of experience
in the biomedical industry and with us and his experience serving in management roles of various companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Christopher
Fashek, Chairman of the Board</i>. </b><span style="background-color: white">Mr. Fashek has served as our director and Chairman of the
Board since November 2016. Mr. Fashek is an accomplished healthcare executive with a record of leading global medical-device and pharmaceutical
businesses. Mr. Fashek led the team that introduced V.A.C.<sup>&#174; </sup>therapy, a negative pressure wound therapy, to both, the clinical
community, and patients with serious or complex wounds. From June 2018, to 2020, Mr. Fashek has served as Chief Executive Officer and
Director of Brain Sentinel, Inc. Mr. Fashek currently serves as a Director of World Craniofacial Foundation (WCF), the Wound Healing
Foundation (WHF), and the American College of Wound Healing and Tissue Repair (ACWHTR). From 1995 to 2007, he was at KCI as the Vice
Chairman, Chief Executive Officer, and President of KCI USA. From 2008 to 2011, he was the Chairman of the Board of Directors at Systagenix,
Ltd. From 2014 to 2015, he was the Chairman of the Board of Directors and Chief Executive Officer of Spiracur, Inc. He currently serves
as Chairman of MedTech Solutions Group, LLC, a startup in San Antonio, Texas. He has a Bachelor of Arts degree from Upsala College and
Master of Business Administration from Fairleigh Dickinson University. Mr. Fashek&#8217;s extensive experience as an executive and leadership
positions in the global medical device and pharmaceutical businesses, as well as his network of industry partners, provide him the appropriate
experience to serve on our Board.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Mr.
Fashek is recognized as developing highly productive and profitable leadership teams and corporate cultures, while taking multiple healthcare
products from idealization to commercialization, as well as turning around under-performing corporations to profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Martin
Goldstein, M.D., Director</i>.</b> <span style="background-color: white">Dr. Goldstein has served as our director since March 25, 2015
and has been a practicing urologist for more than 20 years with particular expertise in the management of stone disease. Dr. Goldstein
is an accomplished healthcare entrepreneur. He is the President of New Jersey Urology, the largest urology group practice in the country.
He also serves as Senior Vice President of Corporate Development and Acquisitions of Urology Management Associates, a private equity
backed entity providing administrative practice management services to independent urology groups. Dr. Goldstein is a co-founder and
executive board member of Metropolitan Surgery Center, a large multispecialty ambulatory surgery center. Dr. Goldstein brings to our
Board his medical practice expertise. He is expected to make a valuable contribution in connection with marketing and facilitating the
acceptance of our product offerings within the medical community. He has provided assistance with the U.S. Food and Drug Administration
regulatory approval process of our products, particularly our urology offerings, and will continue to advise on new product development
and innovations.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Michael
Ferguson, Director</i>.</b> The Honorable Mr. Ferguson has served as our director since April 27, 2015. Mr. Ferguson is currently a senior
advisor at BakerHostetler, serving as the leader of their Federal Policy team. In January 2009, Mr. Ferguson founded Ferguson Strategies,
LLC, a government affairs and strategic business consulting firm, where he served as the chief executive officer and chairman. From 2001
to January 2009, he served in the U.S. House of Representatives, representing New Jersey&#8217;s 7th congressional district. While in
Congress, he was a member of the House Energy and Commerce Committee, which has wide jurisdiction over the healthcare, telecommunications
and energy industries. He served as vice chairman of the panel&#8217;s Health Subcommittee, where he became a key member on health care
issues and helped to ensure passage of the Medicare Part D prescription drug benefit in 2003. In addition, he served as a member of the
Telecommunications and Internet Subcommittee as well as the Oversight and Investigations Subcommittee. Mr. Ferguson was also a member
of the House Financial Services Committee, where he cosponsored the Sarbanes-Oxley Act of 2002 and helped enact the initial terrorism
risk insurance law. Mr. Ferguson was the former chairman of the Board of Commissioners of the New Jersey Sports and Exhibition Authority
and also serves as a senior fellow of the Center for Medicine in the Public Interest&#8217;s Odyssey Initiative for Biomedical Innovation
and Human Health. He has also served on various corporate advisory boards and committees, including for Pfizer, Inc., the National Italian
American Foundation and the United States Golf Association. Mr. Ferguson received a bachelor&#8217;s degree in government from the University
of Notre Dame and a master&#8217;s of public policy degree with a specialization in education policy from Georgetown University. Mr.
Ferguson also formerly served as the Chairman of the Board of Ohr Pharmaceutical Inc. and brings to the Board his extensive background
in government affairs, health care policy, and business strategy gained from his experiences in Congress and business consulting, which
we believe will assist in strengthening and advancing our strategic focus and regulatory compliance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Thomas
R. Mika, Director</i>.</b> Mr. Mika has served as our director since April 27, 2015. Mr. Mika has over 30 years of senior management,
finance and consulting experience. Mr. Mika is currently executive vice president and chief financial officer of POET Technologies, Inc.
(TSX Venture: PTK, NASDAQ:POET) and previously served as chairman of the board of Rennova Health, Inc. (NASDAQ: RNVA) and as chief executive
officer of its wholly owned subsidiary, CollabRx, Inc. (NASDAQ: CLRX). Rennova Health is a vertically integrated public healthcare holding
company that merged with CollabRx in November 2015 and became listed on the NASDAQ. CollabRx, formerly known as Tegal Corporation (NASDAQ:
TGAL), is a clinical decision-support company that delivers expert solutions in precision oncology and genomic medicine. Mr. Mika was
the chairman and chief executive officer of CollabRx and its predecessor company since March 2005. From 1992 to 2002, Mr. Mika served
on the company&#8217;s Board, which included periods of service as the chairman of the compensation committee and a member of the audit
committee. Previously, Mr. Mika co-founded IMTEC, a boutique investment and consulting firm whose areas of focus included health care,
pharmaceuticals, media and information technology. As a partner of IMTEC, Mr. Mika served clients in the United States, Europe and Japan
over a period of 20 years, taking on the role of chief executive officer in several ventures. Earlier in his career, Mr. Mika was a managing
consultant with Cresap, McCormick &amp; Paget and a policy analyst for the National Science Foundation. Mr. Mika holds a bachelor of
science degree in Microbiology from the University of Illinois at Urbana-Champaign and a master of business administration degree from
the Harvard Graduate School of Business. Mr. Mika&#8217;s qualifications to serve on our Board include his significant strategic and
business insight from his prior service on the Board of other publicly held companies, as well as his substantial senior management,
finance and consulting experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aurora
Cassirer<i>, Director</i>.</b> Ms. Cassirer has served as our director since January 2022. She is a highly experienced attorney, who
has served as a partner in prominent law firms for more than 30 years including Troutman Pepper, where she served on the Executive and
Compensation Committees, and Jenkins &amp; Gilchrist. In addition to her management responsibilities, Ms. Cassirer has a sophisticated
practice focusing on business litigation and corporate governance issues. She has developed a particular niche in dealing with publicly
and privately held biotech/healthtech and biopharma companies. Ms. Cassirer has been listed as AV Preeminent by Martindale-Hubbell consistently
for the last 20 years as well as being listed in Law &amp; Politics&#8217; New York Super Lawyers for excellence in Business Litigation
every year since 2008. Previously, she served as Chair of the Advisory Board of ReferWell, f/k/a Urgent Consult, LLC, a start-up in the
health tech business. She also serves on the Board of Directors of Kids in Need of Defense (KIND), a not-for-profit organization where
she served on its Compensation Committee. She is also a member of the Board of Friends of Jerusalem College of Technology and serves
on its Development Committee. She serves as co-chair of the New York State Bar Association International Corporate Compliance Committee
and on the Advisory Board of LiveCare Corp., a company engaged in the manufacturing and distribution of remote monitoring devices of
patients. Ms. Cassirer received her JD from New York University. Ms. Cassirer&#8217;s extensive legal experience and deep knowledge of
corporate governance make her well-qualified to serve on our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Maria
Schroeder<i>, Director</i>.</b> <span style="background-color: white">Ms. Schroeder</span> has served as our director since January 2022.
<span style="background-color: white">Ms. Schroeder has been a key Financial Executive at a number of public and privately-held companies
including CST Brands, KCI and Brain Sentinel, where she recently served as Chief Financial Officer. Prior to Brain Sentinel, Ms. Schroeder
served as Vice President, Global Tax of CST Brands, a Fortune 250 retail Oil and Gas company. Prior to that, she served as Vice President
and Treasurer &amp; Head of Tax at Kinetic Concepts, Inc. (&#8220;KCI&#8221;) a $1.5 billion MedTech company, which was recently purchased
by 3M for $6.7 billion. At KCI, she held key roles in a number of strategic transactions, including two leveraged buyouts and an initial
public offering. Ms. Schroeder began her career at Ernst &amp; Whinney before joining Deloitte Haskins &amp; Sells. Ms. Schroeder is
an alumnus of San Antonio Leadership, a premier leadership program of the San Antonio Chamber of Commerce and has served on the Audit
Committee for The University of Texas at San Antonio, as Treasurer of Girls, Inc. of San Antonio and as a board member of KLRN, San Antonio&#8217;s
public television station. Ms. Schroeder is a Certified Public Accountant and Chartered Global Management Accountant with a B.B.A. in
Accounting from the University of Texas at San Antonio. Ms. Schroeder&#8217;s financial expertise and leadership experience </span>make
her well-qualified to serve on our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the names, ages and positions of our executive officers and certain significant employees as of April 29,
2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Age</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Position</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Murphy</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Brown</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harold
    Jacob, M.D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Medical Officer and Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
see the biography of Mr. Murphy on page 4 of this Amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stephen
Brown</i>. </b>Mr. Brown has served as our chief financial officer since October 5, 2020. Previously, Mr. Brown served as the Company&#8217;s
Chief Financial Officer from February 3, 2015 through April 30, 2019 and continued to serve as a financial consultant for the Company
until his appointment as Chief Financial Officer on October 5, 2020. Mr. Brown previously served as Chief Financial Officer for IDT Corporation
(NYSE: IDT) from April 1995 to January 2009, during which time he oversaw the initial public offering of a start-up telecommunications
company and guided it through the spin-offs of two subsidiaries, various public offerings and bank facilities. During his tenure at IDT,
Mr. Brown also served on IDT&#8217;s board of directors for six years and on the board of directors of Net2Phone Inc. for five years.
Mr. Brown was also the founder and chairman of IDT Entertainment Inc., a movie studio and media subsidiary of IDT. From 2009 to the present,
Mr. Brown has served as a managing partner of The Mcguffin Group Financial, a financial and business consulting firm concentrating on
advising early stage and micro-cap companies. He is also a partner in an accounting and tax practice, Brown, Brown and Associates. Mr.
Brown was formerly a certified public accountant, is a member of the Academy of Television Arts and Sciences and serves on the board
of directors for several educational institutions, including on the Board of Governors for Touro College.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
see the biography of Dr. Jacob on page 4 of this Amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CORPORATE
GOVERNANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NanoVibronix,
Inc., with the oversight of the Board and its committees, operates within a comprehensive plan of corporate governance for the purpose
of defining independence, assigning responsibilities, setting high standards of professional and personal conduct and assuring compliance
with such responsibilities and standards. We regularly monitor developments in the area of corporate governance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Business Conduct and Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a code of business conduct and ethics that applies to all of our officers, directors and employees. The code of business
conduct and ethics addresses, among other things, competition and fair dealing, conflicts of interest, financial matters and external
reporting, our funds and assets, confidentiality and corporate opportunity requirements and the process for reporting violations of the
code of business conduct and ethics, employee misconduct, improper conflicts of interest or other violations. A copy of the code of ethics
was attached as Exhibit 14.1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2016, filed with the Securities
and Exchange Commission on March 31, 2017. If we amend or grant a waiver of one or more of the provisions of our code of business conduct
and ethics, we intend to satisfy the requirements under Item 5.05 of Form 8-K regarding the disclosure of amendments to, or waivers from,
provisions of our code of business conduct and ethics that apply to our principal executive, financial and accounting officers by posting
the required information on our website at www.nanovibronix.com within four business days following the date of such amendment or waiver.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Composition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation and Bylaws provide that our Board will consist of such number of directors as determined from time to time
by resolution adopted by our Board. The size of our Board is currently fixed at eight directors. Subject to any rights applicable to
any then outstanding preferred stock, any vacancies or newly created directorships resulting from an increase in the authorized number
of directors may be filled by a majority of the directors then in office. Each member of our Board is elected for a one-year term and
is elected at each annual meeting of stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no formal policy regarding Board diversity. Our Board believes that each director should have a basic understanding of our principal
operational and financial objectives and plans and strategies, our results of operations and financial condition and relative standing
in relation to our competitors. We take into consideration the overall composition and diversity of the Board and areas of expertise
that director nominees may be able to offer, including business experience, knowledge, abilities and customer relationships. Generally,
we will strive to assemble a Board that brings to us a variety of perspectives and skills derived from business and professional experience
as we may deem are in our and our stockholders&#8217; best interests. In doing so, we will also consider candidates with appropriate
non-business backgrounds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently listed on The NASDAQ Capital Market and therefore rely on the definition of independence set forth in the NASDAQ Listing
Rules (&#8220;NASDAQ Rules&#8221;). Under the NASDAQ Rules, a director only qualifies as an &#8220;independent director&#8221; if, in
the opinion of that company&#8217;s board of directors, that person does not have a relationship that would interfere with the exercise
of independent judgment in carrying out the responsibilities of a director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to be considered to be independent for purposes of Rule 10A-3, a member of an audit committee of a listed company may not, other
than in his or her capacity as a member of the audit committee, the board of directors, or any other board committee: (1) accept, directly
or indirectly, any consulting, advisory or other compensatory fee from the listed company or any of its subsidiaries or (2) be an affiliated
person of the listed company or any of its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board undertook a review of its composition, the composition of its committees and the independence of each director. Based upon information
requested from and provided by each director concerning his or her background, employment and affiliations, including family relationships,
our Board has determined that Christopher Fashek, Michael Ferguson, Martin Goldstein, M.D., Thomas R. Mika, Aurora Cassirer, and Maria
Schroeder or six of our eight directors, do not have a relationship (other than being a director and/or a stockholder) that would interfere
with the exercise of independent judgment in carrying out the responsibilities of a director and that each of these directors is &#8220;independent&#8221;
as that term is defined under the NASDAQ Rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board also determined that (i) Messrs. Thomas Mika and Michael Ferguson and Ms. Maria Schroeder, who compose our audit committee, (ii)
Ms. Aurora Cassirer and Messrs. Thomas Mika and Michael Ferguson, who compose our compensation committee, and (iii) Messrs. Martin Goldstein
and Christopher Fashek and Ms. Aurora Cassirer, who compose our nominating and corporate governance committee, each satisfy the independence
standards for those committees established by the applicable rules and regulations of the SEC and the NASDAQ Rules. In making this determination,
our Board considered the relationships that each non-employee director has with us and all other facts and circumstances our Board deemed
relevant in determining their independence, including the beneficial ownership of our capital stock by each non-employee director. We
intend to comply with all size and independence requirements for committees within the applicable time periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Committees, Meetings and Attendance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2021, the Board held seven meetings. We expect our directors to attend Board meetings, meetings of any committees
and subcommittees on which they serve and each annual meeting of stockholders, either in person or by teleconference. During the year
ended December 31, 2021, each director attended at least 75% of the total number of meetings held by the Board and Board committees of
which such director was a member. Last year&#8217;s annual meeting was not attended by any directors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board currently has three standing committees which consist of an audit committee, a nominating and corporate governance committee and
a compensation committee, each of which has the composition and responsibilities described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of these committees operates under a charter that has been approved by our Board. The current charter of each of these committees is
available on our website at <i>www.nanovibronix.com</i> in the &#8220;Governance&#8221; section under &#8220;Investors.&#8221; The reference
to our website address does not constitute incorporation by reference of the information contained at or available through our website,
and you should not consider it to be a part of this proxy statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee.</b> The audit committee consists of Messrs. Thomas Mika (chair) and Michael Ferguson and Ms. Maria Schroeder, each of whom
our Board has determined to be financially literate and qualify as an independent director under Sections 5605(a)(2) and 5605(c)(2) of
the NASDAQ Rules and Rule 10A-3(b)(1) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). In addition,
Mr. Thomas Mika qualifies as an &#8220;audit committee financial expert,&#8221; as defined in Item 407(d)(5)(ii) of Regulation S-K. Our
Board also determined that each member of our audit committee can read and understand fundamental financial statements in accordance
with applicable requirements. In arriving at these determinations, the Board examined each audit committee member&#8217;s scope of experience
and the nature of their employment in the corporate finance sector.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
function of the audit committee is to assist the Board in its oversight of (1) the integrity of our financial statements, (2) our compliance
with legal and regulatory requirements, (3) the qualifications, independence and performance of our independent auditors and (4) audit
and non-audit fees and services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee met four times during the year ended December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating
and Corporate Governance Committee.</b> The nominating and corporate governance committee consist of Messrs. Christopher Fashek (chair)
and Martin Goldstein, Ms. Aurora Cassirer and Ms. Maria Schroeder, each of whom our Board has determined qualifies as an independent
director under Section 5605(a)(2) of the NASDAQ Rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary function of the nominating and corporate governance committee is to identify individuals qualified to become board members, consistent
with criteria approved by the Board, and select the director nominees for election at each annual meeting of stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
nominating and corporate governance committee met one time during the year ended December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee.</b> The compensation committee consists of Messrs. Michael Ferguson (chair) and Thomas Mika and Ms. Aurora Cassirer, each
of whom our Board has determined qualifies as an independent director under Sections 5605(a)(2) and 5605(d)(2) of the NASDAQ Rules, as
an &#8220;outside director&#8221; for purposes of Section 162(m) of the Internal Revenue Code and as a &#8220;non-employee director&#8221;
for purposes of Section 16b-3 under the Exchange Act. The function of the compensation committee will be to discharge the Board&#8217;s
responsibilities relating to compensation of our directors and executives and our overall compensation programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary objective of the compensation committee will be to develop and implement compensation policies and plans that are appropriate
for us in light of all relevant circumstances and which provide incentives that further our long-term strategic plan and are consistent
with our culture and the overall goal of enhancing enduring stockholder value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation committee met three times during the year ended December 31, 2021 and engaged an employment consulting firm in determining
and recommending the amount or form of executive and director compensation during the year ended December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Leadership Structure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board is committed to promoting our effective, independent governance. Our Board believes it is in our best interests and the best interests
of our stockholders for the Board to have the flexibility to select the best director to serve as chairman at any given time, regardless
of whether that director is an independent director or the chief executive officer. Consequently, we do not have a policy governing whether
the roles of chairman of the Board and chief executive officer should be separate or combined. This decision is made by our Board, based
on our best interests considering the circumstances at the time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
the offices of the chairman of the Board and the chief executive officer are held by two different people. Christopher Fashek is our
independent, non-executive chairman of the Board, and Brian Murphy is our chief executive officer. The chief executive officer will be
responsible for our day-to-day leadership and performance, while the chairman of the Board will provide guidance to the chief executive
officer and set the agenda for board meetings and preside over meetings of the Board. We believe that separation of the positions will
reinforce the independence of the Board in its oversight of our business and affairs, and create an environment that is more conducive
to objective evaluation and oversight of management&#8217;s performance, increasing management accountability and improving the ability
of the Board to monitor whether management&#8217;s actions are in our best interests and those of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Role
in Risk Oversight</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board oversees an enterprise-wide approach to risk management, designed to support the achievement of business objectives, including
organizational and strategic objectives, to improve long-term organizational performance and enhance stockholder value. The involvement
of our Board in setting our business strategy is a key part of its assessment of management&#8217;s plans for risk management and its
determination of what constitutes an appropriate level of risk for the company. The participation of our Board in our risk oversight
process includes receiving regular reports from members of senior management on areas of material risk to our company, including operational,
financial, legal and regulatory, and strategic and reputational risks, including cybersecurity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board continually reviews the Company&#8217;s controls and procedures that involve cybersecurity matters to determine the potential material
impact to our financial results, operations, and/or reputation to insure such incidents are immediately reported by management to the
Board, or individual members or committees thereof, as appropriate, in accordance with our escalation framework.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
our Board has the ultimate responsibility for the risk management process, senior management and various committees of our Board will
also have responsibility for certain areas of risk management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
senior management team is responsible for day-to-day risk management and regularly reports on risks to our full Board or a relevant committee.
Our finance and regulatory personnel serve as the primary monitoring and evaluation function for company-wide policies and procedures,
and manage the day-to-day oversight of the risk management strategy for our ongoing business. This oversight includes identifying, evaluating,
and addressing potential risks that may exist at the enterprise, strategic, financial, operational, compliance and reporting levels.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee will focus on monitoring and discussing our major financial risk exposures and the steps management has taken to monitor
and control such exposures, including our risk assessment and risk management policies. As appropriate, the audit committee will provide
reports to and receive direction from the full Board regarding our risk management policies and guidelines, as well as the audit committee&#8217;s
risk oversight activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the compensation committee will assess our compensation policies to confirm that the compensation policies and practices do
not encourage unnecessary risk taking. The compensation committee will review and discuss the relationship between risk management policies
and practices, corporate strategy and senior executive compensation and, when appropriate, report on the findings from the discussions
to our Board. Our compensation committee intends to set performance metrics that will create incentives for our senior executives that
encourage an appropriate level of risk-taking that is commensurate with our short-term and long-term strategies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Communications
with Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board welcomes communication from our stockholders. Stockholders and other interested parties who wish to communicate with a member or
members of our Board or a committee thereof may do so by addressing correspondence to the Board member, members or committee, c/o NanoVibronix,
Inc., 525 Executive Blvd, Elmsford, NY 10523, ATTN: Brian Murphy, Chief Executive Officer. Our Chief Executive Officer will review and
forward correspondence to the appropriate person or persons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
communications received as set forth in the preceding paragraph will be opened by the Chief Executive Officer for the sole purpose of
determining whether the contents represent a message to our directors. Any contents that are not in the nature of advertising, promotions
of a product or service or patently offensive material will be forwarded promptly to the addressee(s). In the case of communications
to the Board or any group or committee of directors, the Chief Executive Officer will make sufficient copies of the contents to send
to each director who is a member of the group or committee to whom the communication is addressed. If the amount of correspondence received
through the foregoing process becomes excessive, our Board may consider approving a process for review, organization and screening of
the correspondence by the corporate secretary or another appropriate person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Family
Relationships and Involvement in Certain Legal Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships among our directors and executive officers, or person nominated or chosen by the Company to become a director
or executive officer. To our knowledge, there have been no material legal proceedings as described in Item 401(f) of Regulation S-K that
are material to an evaluation of the ability or integrity of any of our directors or executive officers, or person nominated to become
a director or executive officer (in the last ten years) or our control persons (in the last year).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>ITEM
11. EXECUTIVE COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the names and positions of: (i) each person who served as our principal executive officer during the year
ended December 31, 2021; (ii) our most highly compensated executive officer, other than our principal executive officer, who was serving
as an executive officer, as determined in accordance with the rules and regulations promulgated by the SEC, as of December 31, 2021,
with compensation of $100,000 or more, and (iii) an additional individual for whom disclosure would have been provided pursuant to clause
(ii) but for the fact that the individual was not serving as our executive officer at December 31, 2021 (collectively our &#8220;Named
Executive Officers&#8221;):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 48%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Murphy</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen Brown</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth all compensation earned, in all capacities, during the fiscal years ended December 31, 2021 and 2020 by the
Company&#8217;s named executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name and Principal</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></p></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Salary <br /> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Bonus<br /> ($)(1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option Awards<br /> ($)(2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">All Other Compensation<br /> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total<br /> ($)(2)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Brian Murphy</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">2021</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">231,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">88,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">85,939</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">404,939</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">231,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,599</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">364,599</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stephen Brown (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,485</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">271,485</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,485</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">138,000</td><td style="text-align: left">(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">234,985</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    incentive compensation payments earned.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    accordance with SEC rules, the amounts in this column reflect the dollar amounts to be recognized for financial statement reporting
    purposes with respect to the twelve-month period ended December 31, 2021 in accordance with ASC Topic 718. Fair value is based on
    the Black-Scholes option pricing model using the market price of the underlying shares at the grant date. For additional discussion
    of the valuation assumptions used in determining stock-based compensation and the grant date fair value for stock options, see &#8220;Management&#8217;s
    Discussion and Analysis of Financial Condition and Results of Operation - Critical Accounting Policies - Stock-based compensation&#8221;
    and Note 3&#8212;&#8221;Significant Accounting Policies&#8221; and Note 7&#8212;&#8221;Stockholders&#8217; Equity (Deficiency)&#8221;
    to our audited consolidated financial statements for the fiscal year ended December 31, 2021, included in the 2020 Annual Report.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Brown resigned as our chief financial officer on May 31, 2019 and continued to serve as a financial consultant for thereafter. Mr.
    Brown was appointed again as our chief financial officer, effective October 5, 2020. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    $138,000 paid pursuant to a consulting arrangement during 2020 before Mr. Brown&#8217;s employment by the Company on October 5, 2020.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Narrative
Disclosure to Summary Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into agreements with each of our Named Executive Officers. A description of each of these agreements follows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Brian
Murphy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 13, 2016, we entered into an employment agreement with Mr. Murphy, effective as of the same date. Under the terms of the employment
agreement, the term of Mr. Murphy&#8217;s employment as the chief executive officer of the Company is three years unless earlier terminated.
The employment agreement expired on October 13, 2019. After that date, Mr. Murphy became an employee at will.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the employment agreement, Mr. Murphy was entitled to an annual base salary of $181,000 less applicable payroll deductions and tax withholdings
for all services rendered by him under the employment agreement. Notwithstanding the foregoing, his base salary was automatically increased
to: (i) $200,000, less applicable payroll deductions and tax withholdings, effective as of January 1 of the calendar year immediately
following any calendar year during which we generated gross sales (as determined in accordance with generally accepted accounting principles
consistently applied) exceeding $1,000,000; and (ii) $225,000, less applicable payroll deductions and tax withholdings, effective as
of January 1 of the calendar year immediately following any calendar year during which we generated gross sales (as determined in accordance
with generally accepted accounting principles consistently applied) exceeding $2,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the employment agreement, commencing in 2017, Mr. Murphy was eligible to receive an annual bonus (&#8220;Performance Bonus&#8221;)
during each year of the term of the agreement. For 2019 and 2020, Mr. Murphy was eligible to receive a target bonus in an amount of up
to $100,000, less applicable payroll deductions and tax withholdings, based on the extent to which Mr. Murphy has met performance criteria
for the year, as determined in good faith by the Board, which shall be paid in the calendar year after the calendar year to which the
Performance Bonus relates within thirty (30) days of our issuance of our audited financial statements on Form 10-K. In 2019 and 2020,
Mr. Murphy received a target bonus in an amount of $57,231 and $90,000, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Murphy&#8217;s employment agreement also contained certain noncompetition, non-solicitation, non-disparagement, confidentiality and assignment
of work product requirements for Mr. Murphy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2018, the compensation committee voted to increase Mr. Murphy&#8217;s annual base salary to $231,000 per year and a discretionary
annual bonus of $100,000 to be decided by the compensation committee annually.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 1, 2022, we entered into a new employment agreement with Mr. Murphy (the &#8220;2022 Murphy Employment Agreement&#8221;), with
an annual base salary of $300,000 less applicable payroll deductions and tax withholdings for all services rendered by him under the
2022 Murphy Employment Agreement and a target bonus in an amount of up to $100,000, less applicable payroll deductions and tax withholdings,
based on the extent to which Mr. Murphy has met performance criteria for the year, as determined in good faith by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, pursuant to the 2022 Murphy Employment Agreement, Mr. Murphy is eligible to receive certain stock options, restricted stock,
stock appreciation rights or similar stock-based rights granted to Mr. Murphy as set forth separately in applicable award agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2022 Murphy Employment Agreement has a term of two years and also contains certain noncompetition, non-solicitation, non-disparagement,
confidentiality and assignment of work product requirements for Mr. Murphy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2021 and December 31, 2020, the compensation committee approved performance bonuses of $88,000 and $90,000,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stephen
Brown</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Brown resigned as our chief financial officer on May 31, 2019. On July 1, 2019, we entered into a consulting agreement with The Mcguffin
Group LLC, pursuant to which Mr. Brown was entitled to $12,500 per month, paid monthly, for his services as a finance consultant. He
was also entitled to an annual bonus consistent with bonuses received by consultant in previous years. This agreement was terminated
on October 5, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 5, 2020, we entered into an Employment Agreement with Stephen Brown, pursuant to which we appointed Mr. Brown as Chief Financial
Officer, effective October 5, 2020, with a term to continue in effect until terminated by either party. As consideration for his services
as Chief Financial Officer, Mr. Brown is entitled to receive (i) an annual base salary of $200,000, less applicable payroll deductions
and tax; (ii) reimbursement of any reasonable and customary, documented out-of-pocket expenses actually incurred by Mr. Brown in connection
with the performance of his services under the Employment Agreement; and (iii) an annual bonus of $25,000, if earned, as determined by
us in our sole discretion. Mr. Brown is also eligible to receive certain grants of incentive stock options to purchase shares of our
common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 1, 2022, we entered into a new employment agreement with Mr. Brown (the &#8220;2022 Brown Employment Agreement&#8221;), with
an annual base salary of $250,000 less applicable payroll deductions and tax withholdings for all services rendered by him under the
employment agreement and a target bonus in an amount of up to $50,000, less applicable payroll deductions and tax withholdings, based
on the extent to which Mr. Brown has met performance criteria for the year, as determined in good faith by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2022 Brown Employment Agreement has a term of two years and also contains certain noncompetition, non-solicitation, non-disparagement,
confidentiality and assignment of work product requirements for Mr. Brown.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2021 and December 31, 2020, the compensation committee approved performance bonus of $50,000 and $20,000,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Retirement,
Health, Welfare and Additional Benefits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our Named Executive Officers are eligible to participate in our employee benefit plans and programs, including medical benefits, to
the same extent as our other full-time employees, subject to the terms and eligibility requirements of those plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Retirement,
Health, Welfare and Additional Benefits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our Named Executive Officers are eligible to participate in our employee benefit plans and programs, including medical benefits, to
the same extent as our other full-time employees, subject to the terms and eligibility requirements of those plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2004
Global Share Option Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2004, our Board adopted the 2004 Global Share Option Plan, pursuant to which 400,000 shares of our common stock are reserved
for issuance as awards to employees, directors, consultants and other service providers. The purpose of the 2004 Global Share Option
Plan is to provide an incentive to attract and retain directors, officers, consultants, advisors and employees, to encourage a sense
of proprietorship and stimulate an active interest of such persons in our development and financial success. The 2004 Global Share Option
Plan which was administered by our Board expired on February 28, 2014.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NanoVibronix,
Inc. 2014 Long-Term Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2014, our stockholders approved the NanoVibronix, Inc. 2014 Long-Term Incentive Plan (the &#8220;2014 Plan&#8221;), which
was adopted by our Board on February 19, 2014.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2014 Plan, we originally reserved a total of five million (5,000,000) shares of our common stock for issuance pursuant to awards
to key employees, key contractors, and non-employee directors, of which, the maximum number of shares of common stock covering awards
of stock options or stock appreciation rights that could be granted to certain of our executive officers during any calendar year was
one million (1,000,000) shares. On May 7, 2014, we effected a one-for-seven reverse stock split of our common stock. Consequently, the
number of shares of our common stock reserved for issuance pursuant to awards under the 2014 Plan was reduced to seven hundred fourteen
thousand two hundred eighty-six (714,286) shares, and the maximum number of shares of our common stock covered by awards of stock options
or stock appreciation rights that could be granted to certain of our executive officers during any calendar year was reduced to one hundred
forty-two thousand eight hundred fifty-seven (142,857) shares. On June 13, 2018, the stockholders approved an amendment to the 2014 Plan
to increase the number of shares of our common stock reserved for issuance pursuant to awards under the 2014 Plan by an additional seven
hundred and fifty thousand (750,000) shares of our common stock to one million four hundred sixty-four thousand two hundred eighty-six
(1,464,286) shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 13, 2019, the stockholders approved a second amendment to increase (i) the number of shares of our common stock available for issuance
pursuant to awards under the 2014 Plan by four hundred thousand (400,000) shares of our common stock, to a total of one million eight
hundred and sixty-four thousand two hundred eighty-six (1,864,286) shares of our common stock and (ii) the maximum number of shares of
our common stock covering awards of stock options or stock appreciation rights that could be granted to certain of our executive officers
during any calendar year was increased to three hundred fifty-four thousand two hundred fourteen (354,214).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2014 Plan provides for the granting of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock,
restricted stock units, performance awards, dividend equivalent rights, and other awards, which may be granted singly, in combination,
or in tandem, and which may be paid in cash, shares of our common stock, or a combination of cash and shares of our common stock. We
have reserved a total of 1,864,286 shares of our common stock for awards under the 2014 Plan, 100% of which may be delivered pursuant
to incentive stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the 2014 Plan is to provide an incentive to attract and retain services of key employees, key contractors, and outside directors
whose services are considered valuable, to encourage a sense of proprietorship and to stimulate active interest of such persons in our
development and financial success. The 2014 Plan is intended to serve as an &#8220;umbrella&#8221; plan for us and our subsidiaries worldwide.
Therefore, if so required, appendices may be added to the 2014 Plan in order to accommodate local regulations in foreign countries that
do not correspond to the scope of the 2014 Plan. Unless terminated earlier by the Board, the 2014 Plan will expire on February 19, 2024.
As of December 31, 2021, there were 115,742 options available for future issuance under the 2014 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
of the 2014 Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purpose.
</i>The purpose of the 2014 Plan is to enable us to remain competitive and innovative in our ability to attract and retain the services
of key employees, key contractors, and non-employee directors. The 2014 Plan provides for the granting of incentive stock options, nonqualified
stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalent rights, and
other awards, which may be granted singly, in combination, or in tandem, and which may be paid in cash or shares of our common stock.
The 2014 Plan is expected to provide flexibility to our compensation methods in order to adapt the compensation of key employees, key
contractors, and non-employee directors to a changing business environment, after giving due consideration to competitive conditions
and the impact of applicable tax laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Effective
Date and Expiration.</i> The 2014 Plan was originally approved by our Board on February 19, 2014, and became effective upon stockholder
approval on February 28, 2014. The 2014 Plan will terminate on February 19, 2024, unless sooner terminated by our Board. No award may
be made under the 2014 Plan after its termination date, but awards made prior to the termination date may extend beyond that date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share
Authorization.</i> Subject to certain adjustments, the number of shares of our common stock that are reserved for issuance pursuant to
awards under the 2014 Plan is one million eight hundred and sixty-four thousand two hundred eighty- six (1,864,286) shares, of which
100% may be delivered pursuant to incentive stock options. Subject to certain adjustments, with respect to any participant who is an
officer of our company and subject to Section 16 of the Exchange Act, or a &#8220;covered employee&#8221; as defined in Section 162(m)(3)
of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), a maximum of three hundred fifty four thousand two hundred
fourteen (354,214) shares may be granted in any one year in the form of stock options or stock appreciation rights to such participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
to be issued may be made available from authorized but unissued shares of our common stock, shares held by us in our treasury, or
shares purchased by us on the open market or otherwise. During the term of the 2014 Plan, we will at all times reserve and keep
enough shares available to satisfy the requirements of the 2014 Plan. If an award under the 2014 Plan is cancelled, forfeited, or
expires, in whole or in part, the shares subject to such forfeited, expired, or cancelled award may again be awarded under the 2014
Plan. In the event that previously acquired shares are delivered to us in full or partial payment of the option price for the
exercise of a stock option granted under the 2014 Plan, the number of shares available for future awards under the 2014 Plan shall
be reduced only by the net number of shares issued upon the exercise of the stock option or settlement of an award. Awards that may
be satisfied either by the issuance of common stock or by cash or other consideration shall be counted against the maximum number of
shares that may be issued under the 2014 Plan only during the period that the award is outstanding or to the extent the award is
ultimately satisfied by the issuance of shares. An award will not reduce the number of shares that may be issued pursuant to the
2014 Plan if the settlement of the award will not require the issuance of shares, as, for example, a stock appreciation right that
can be satisfied only by the payment of cash. Only shares forfeited back to us; shares cancelled on account of termination,
expiration, or lapse of an award; shares surrendered in payment of the option price of an option; or shares withheld for payment of
applicable employment taxes and/or withholding obligations resulting from the exercise of a stock option shall again be available
for grant as incentive stock options under the 2014 Plan, but shall not increase the maximum number of shares described above as the
maximum number of shares that may be delivered pursuant to incentive stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Administration.
</i>The 2014 Plan is administered by the compensation committee of our Board (the &#8220;Committee&#8221;). At any time there is no Committee
to administer the 2014 Plan, any reference to the Committee is a reference to the Board. The Committee will determine the persons to
whom awards are to be made; determine the type, size, and terms of awards; interpret the 2014 Plan; establish and revise rules and regulations
relating to the 2014 Plan and any sub-plans, including, without limitation, any sub-plans for awards made to participants who are not
residents of the United States; establish performance goals for awards and certify the extent of their achievement; and make any other
determinations that it believes necessary for the administration of the 2014 Plan. The Committee may delegate certain duties to one or
more of our officers as provided in the 2014 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Eligibility.
</i>Employees (including any employee who is also a director or an officer), contractors, and non-employee directors of us or our subsidiaries
whose judgment, initiative, and efforts contributed to or may be expected to contribute to our successful performance are eligible to
participate in the 2014 Plan. As of the April 29, 2022, we had 8 employees, 9 contractors, and 5 directors who would be eligible
for awards under the 2014 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Options.</i> The Committee may grant either incentive stock options (&#8220;ISOs&#8221;) qualifying under Section 422 of the Code or
nonqualified stock options, provided that only employees of us and our subsidiaries (excluding subsidiaries that are not corporations)
are eligible to receive ISOs. Stock options may not be granted with an option price less than 100% of the fair market value of a share
of common stock on the date the stock option is granted. If an ISO is granted to an employee who owns or is deemed to own more than 10%
of the combined voting power of all classes of our stock (or any parent or subsidiary), the option price shall be at least 110% of the
fair market value of a share of common stock on the date of grant. The Committee will determine the terms of each stock option at the
time of grant, including, without limitation, the methods by or forms in which shares will be delivered to participants. The maximum
term of each option, the times at which each option will be exercisable, and provisions requiring forfeiture of unexercised options at
or following termination of employment or service generally are fixed by the Committee, except that the Committee may not grant stock
options with a term exceeding 10 years or, in the case of an ISO granted to an employee who owns or is deemed to own more than 10% of
the combined voting power of all classes of our stock (or any parent or subsidiary), a term exceeding five years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at Fiscal Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information on the holdings of stock options of the Named Executive Officer at December 31, 2021. This table
includes unexercised and unvested options awards. Each outstanding award is shown separately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="16" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option Awards</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Date of</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options (#)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options (#)</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Grant</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercisable</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercisable</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 17%; text-align: left">Brian Murphy (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 16%; text-align: center">October 1, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">50,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160,000</span></td><td style="width: 1%; text-align: left">(2)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.72</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2, 2030</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">December 23, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.84</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 24, 2030</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">(4)</td><td>&#160;</td>
    <td style="text-align: center">December 29, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">300,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 29, 2031 </span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stephen Brown (1)</td><td>&#160;</td>
    <td style="text-align: center">October 1, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2, 2030</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">December 23, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td><td style="text-align: left">(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,000</span></td><td style="text-align: left">(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.84</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 24, 2030</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">(4)</td><td>&#160;</td>
    <td style="text-align: center">December 29,2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 29, 2031 </span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
On November 2, 2020, we entered into an option cancellation and release agreement with Brian Murphy and Stephen Brown, pursuant to which
the parties agreed to cancel options to purchase an aggregate of 296,020 shares of our common stock at exercise prices ranging from $2.57
to $6.00 (the &#8220;Options&#8221;) previously granted to each of the Option holders. In exchange for the cancellation of the Options,
we paid $1.00 to each Option holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
These options vest 20% on March 23, 2021, 20% on June 23, 2021, 20% on September 23, 2021 and 20% on December 23, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
These options vest 20% on March 23, 2021, 20% on June 23, 2021, 20% on September 23, 2021 and 20% on December 23, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
These options vest 8.3% on March 29, 2022 and 8.3% every subsequent three months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIRECTOR
COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the compensation earned by persons who served on our Board during the fiscal year ended December 31, 2021, who
are not one of our named executive officers. Other than as set forth in the table and described more fully below, we did not pay any
compensation, reimburse any expense of, make any equity awards or non-equity awards to, or pay any other compensation to any of the other
members of our Board for their services rendered in such period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fees earned<br /> or paid<br /> in cash ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option <br /> Awards ($) (1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Christopher Fashek (2)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">150,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">64,824</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">214,824</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Thomas Mika (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,618</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,618</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Michael Ferguson (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,055</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,055</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Martin Goldstein (5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,070</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,070</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Harold Jacob, M. D. (6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,288</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,288</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
In accordance with SEC rules, the amounts in this column reflect the dollar amounts to be recognized for financial statement reporting
purposes with respect to the 2021 fiscal year in accordance with ASC Topic 718. Fair value is based on the Black-Scholes option pricing
model using the market price of the underlying shares at the grant date. For additional discussion of the valuation assumptions used
in determining stock-based compensation and the grant date fair value for stock options, see &#8220;Management&#8217;s Discussion and
Analysis of Financial Condition and Results of Operation - Critical Accounting Policies - Stock-based compensation&#8221; and Note 3&#8212;&#8221;Significant
Accounting Policies&#8221; and Note 6&#8212;&#8221;Stockholders&#8217; Equity&#8221; to our audited consolidated financial statements
for the fiscal year ended December 31, 2021, included in the Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
As of December 31, 2021, Mr. Fashek had outstanding options representing the right to purchase 292,000 shares of our common stock and
no outstanding stock awards of shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
As of December 31, 2021, Mr. Mika had outstanding options representing the right to purchase 220,000 shares of our common stock and no
outstanding stock awards of shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
As of December 31, 2021, Mr. Ferguson had outstanding options representing the right to purchase 205,000 shares of our common stock and
no outstanding stock awards of shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
As of December 31, 2021, Mr. Goldstein had outstanding options representing the right to purchase 254,000 shares of our common stock
and no outstanding stock awards of shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
As of December 31, 2021, Dr. Jacob had outstanding options representing the right to purchase 169,285 shares of our common stock and
no outstanding stock awards of shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 13, 2016, we entered into an agreement with Christopher Fashek to serve as the chairman of our Board. Under this agreement Mr.
Fashek was paid $100,000 per year payable in semi-monthly installments. On November 1, 2018, the Compensation committee voted to increase
Mr. Fashek&#8217;s consulting fee to $150,000 per year. Mr. Fashek is also entitled to receive a year-end bonus of up to $25,000 to be
determined by the compensation committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 2, 2020, the Company entered into an option cancellation and release agreement with each of Brian Murphy, Christopher Fashek,
Martin Goldstein, Michael Ferguson, Stephen Brown, and Thomas Mika (collectively, the &#8220;Option holders&#8221;), pursuant to which
the parties agreed to cancel options to purchase an aggregate of 804,788 shares of common stock of the Company at exercise prices ranging
from $2.57 to $6.00 (the &#8220;Options&#8221;) previously granted to each of the Optionholders. In exchange for the cancellation of
the Options, the Company paid $1.00 to each Optionholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outside
of compensation to our chairman, Christopher Fashek, we paid no compensation to our non-employee directors for the one-year period ended
December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Ownership of Certain Beneficial Owners and Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information with respect to the beneficial ownership of our common stock as of April 29, 2022 by:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each person known by us to beneficially own more than
    5.0% of our common stock;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each of our directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each of the Named Executive Officers; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all of our directors and executive officers as a group.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
percentages of common stock beneficially owned are reported on the basis of regulations of the SEC governing the determination of beneficial
ownership of securities. Under the rules of the SEC, a person is deemed to be a beneficial owner of a security if that person has or
shares voting power, which includes the power to vote or to direct the voting of the security, or investment power, which includes the
power to dispose of or to direct the disposition of the security.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as indicated in the footnotes to this table, each beneficial owner named in the table below has sole voting and sole investment power
with respect to all shares beneficially owned and each person&#8217;s address is c/o NanoVibronix, Inc., 525 Executive Blvd, Elmsford,
NY 10523. As of April 29, 2022, we had 27,997,793 shares of common stock, 0 shares of Series C Preferred Stock, 0 shares of Series
D Preferred Stock and 0 shares of Series E Preferred Stock outstanding. In addition to the shares of common stock reported below, as
described in the footnotes below the table, one stockholder beneficially owns 100% of our issuable and issued Series C Preferred Stock
and one stockholder beneficially owns 100% of our issuable and issued Series E Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of
    Beneficial Owner</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beneficially</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Owned
    (1)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
    Shares<br />
 Outstanding <br />
(1)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5% Owners</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors and Officers</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen Brown</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116,600</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harold Jacob, M.D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">222,611</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.0</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin Goldstein, M.D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">241,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.0</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Ferguson</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">190,625</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.0</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas R. Mika</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">205,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.0</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher Fashek</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Murphy</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">299,800</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aurora Cassirer </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maria Schroeder</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All directors and executive officers as a group (9
    persons)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,573,162</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.62</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Common Stock beneficially owned and the respective percentages of beneficial ownership of Common Stock assume the exercise of
    all options, warrants and other securities convertible into Common Stock beneficially owned by such person or entity currently exercisable
    or exercisable within 60 days of April 29, 2022. Shares issuable pursuant to the exercise of stock options and warrants exercisable
    within 60 days are deemed outstanding and held by the holder of such options or warrants for computing the percentage of outstanding
    Common Stock beneficially owned by such person, but are not deemed outstanding for computing the percentage of outstanding Common
    Stock beneficially owned by any other person.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprised
    of 116,600 shares of stock that may be purchased by Mr. Brown upon exercise of stock options that are currently exercisable or exercisable
    within 60 days following April 29, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprised
    of (i) 64,178 shares of Common Stock held by Medical Instrument Development Inc., an entity controlled by Dr. Jacob, (ii) 12,362
    shares of Common Stock held by Dr. Jacob, and (iii) 156,785 shares of Common Stock that may be purchased by Dr. Jacob upon the exercise
    of stock options.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprised
    of 241,500 shares of stock that may be purchased by Dr. Goldstein upon exercise of stock options that are currently exercisable or
    exercisable within 60 days following April 29, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprised
    of 190,625 shares of stock that may be purchased by Mr. Ferguson upon exercise of stock options that are currently exercisable or
    exercisable within 60 days following April 29, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprised
    of 205,000 shares of stock that may be purchased by Mr. Mika upon exercise of stock options that are currently exercisable or exercisable
    within 60 days following April 29, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprised
    of 25,000 shares of Common Stock held by Mr. Fashek and 272,000 shares of stock that may be purchased by Mr. Fashek upon exercise
    of stock options that are currently exercisable or exercisable within 60 days following April 29, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprised
    of 299,800 shares of stock that may be purchased by Mr. Murphy upon exercise of stock options that are currently exercisable or exercisable
    within 60 days following April 29, 2022.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Compensation Plan Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides certain information as of December 31, 2021 with respect to our equity compensation plans under which our equity
securities are authorized for issuance:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(a)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(b)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(c)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Plan Category</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br />
 securities to</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>be issued upon exercise of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>outstanding<br />
 options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrants, and<br />
 rights</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br />
average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise price <br />
of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>outstanding<br />
 options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrants and <br />
rights</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of <br />
securities remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>available for future<br />
 issuance under</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>equity <br />
compensation plans<br />
 (excluding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>securities reflected <br />
in column (a))</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold; text-align: left">Equity compensation plans approved by security holders (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">2,539,999</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1.05</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Equity compensation plans not approved by security holders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,539,999</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents shares available
    for issuance under the 2014 Plan.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
we do not enter into related party transactions unless the members of the Board who do not have an interest in the potential transaction
have reviewed the transaction and determined that (i) we would not be able to obtain better terms by engaging in a transaction with a
non-related party and (ii) the transaction is in our best interest. In approving or rejecting any such proposal, our Board considers
all of the relevant facts and circumstances of the related party transaction and the related party&#8217;s relationship and interest
in the transaction. This policy applies generally to any transaction in which we are to be a participant and the amount involved exceeds
the lesser of $120,000 or one percent of the average of our total assets at year-end for the previous two completed fiscal years, and
in which any related person had or will have a direct or indirect material interest. This policy is not currently in writing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee is charged with reviewing, approving and overseeing any transaction between the Company and any related person (as defined
in Item 404 of Regulation S-K) and any other potential conflict of interest situations in accordance with Company policies and procedures.
All of the transactions described below were entered into prior to the establishment of our audit committee and were evaluated in accordance
with the policy described in the paragraph above. Prior to approving such transactions, the material facts as to a director&#8217;s or
officer&#8217;s relationship or interest as to the agreement or transaction were disclosed to our Board. Our Board took this information
into account when evaluating the transaction and in determining whether such transaction was fair to us and in the best interest of all
of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transactions
with Related Parties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than compensation agreements and other arrangements which are described as required under &#8220;Director Compensation&#8221; and &#8220;Executive
Compensation&#8221; and the transactions described below, since January 1, 2018, there has not been, and there is not currently proposed,
any transaction or series of similar transactions to which we were or will be a party in which the amount involved exceeded or will exceed
the lesser of $120,000 or the average of our total assets at year-end for the last two completed fiscal years and in which any director,
executive officer, holder of 5% or more of any class of our capital stock, or any member of their immediate family had or will have a
direct or indirect material interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrant
Exercises</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 21, 2021, Company entered into letter agreements (the &#8220;Letter Agreements&#8221;) with certain existing accredited investors
to exercise certain outstanding warrants (the &#8220;Existing Warrants&#8221;) to purchase up to an aggregate of 1,205,967 shares of
the Company&#8217;s common stock at an exercise price per share of $1.165 (the &#8220;Exercise&#8221;). Certain of the Existing Warrants
(the &#8220;Registered Existing Warrants&#8221;) and the shares of common stock underlying the Registered Existing Warrants have been
registered pursuant to a registration statement on Form S-3 (File No. 333-251264) and a registration statement on Form S-1 (File No.
333-218871). In consideration for the exercise of the Existing Warrants for cash, the exercising holders will receive new unregistered
warrants to purchase up to an aggregate of 1,205,967 shares of common stock (the &#8220;New Warrants&#8221;) at an exercise price of
$1.04 per share and with an exercise period of seven years from the initial closing date of January 22, 2021. The gross proceeds to the
Company from the Exercise were approximately $1.4 million. The Company currently intends to use the net proceeds from the Exercise for
working capital and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Option
Cancellation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 2, 2020, we entered into an option cancellation and release agreement with the several Option holders, pursuant to which the
parties agreed to cancel the Options previously granted to each of the Option holders. In exchange for the cancellation of the Options,
we paid $1.00 to each Option holder. See &#8220;Director Compensation.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
members resignation and severance agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 25, 2015, we entered into an agreement with Dr. Goldstein, a member of our Board, pursuant to which, as consideration for his efforts
developing, pursuing approval of, and/or raising market awareness and acceptance of our UroShield product and CathBot product and any
other future vibrating urology catheter-related product, Dr. Goldstein is entitled to a fee of $62.50 per unit of such products sold
by us in the United States or Canada during the term of the agreement, less applicable deductions and tax withholdings. At our option,
the per unit fees may be paid in the form of cash or shares of our common stock. If any portion is paid in cash, within 30 days of receipt,
Dr. Goldstein must purchase an amount of common stock in the open market, subject to any limitations or restrictions that may apply under
applicable laws, such that the purchase price of the common stock purchased plus the value of any common stock provided as payment of
the per unit fees in the given quarter equals at least 50% of the per unit fees paid for that quarter (less applicable taxes). The term
of the agreement continues until terminated. Either party may terminate the agreement for any reason by providing 90 days prior written
notice to the other party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Zumeris served our director from September 2003 to July 2018. On July 4, 2018, we and Dr. Zumeris and his wife, Janina (Ina) Zumeris
entered into a Separation and Release Agreement (the &#8220;Separation Agreement&#8221;). Upon meeting certain milestones to our satisfaction
and fulfilling other obligations under the Separation Agreement, (i) Dr. Zumeris and Janina Zumeris, was entitled to receive as consulting
payments an aggregate of approximately $18,000 per month for 12 months, commencing 30 days after the Termination Date; (ii) our management,
beginning on November 4, 2018, was required to use our best efforts to allow the sale of the Company&#8217;s securities owned by Dr.
Zumeris, provided that such sale would be in compliance with the applicable U.S. securities laws and regulations, and provided further,
that, if our shares of common stock held by Dr. Zumeris had not been sold at a price lower than $4.45 during the fourteen month period
from July 4, 2018, and the value of the unsold securities Dr. Zumeris owned plus the value of cash received by Dr. Zumeris from the sale
of our securities during such fourteen month period (the &#8220;Aggregate Amount&#8221;), in aggregate, was less than $950,000, then
we were required to make up the difference between $950,000 and the Aggregate Amount by extending the term of engagement of Dr. Zumeris
and Janina Zumeris&#8217;s consulting services. In addition, if we (i) granted a license for the skin rejuvenation technology, then we
were required pay Dr. Zumeris 10% from the payments received by the Company until an aggregate amount of $100,000,000 was paid to Dr.
Zumeris, (ii) sold the skin rejuvenation technology and/or the rights to such as a standalone product, we were required to pay Dr. Zumeris
$100,000 from the proceeds of such sale, or (iii) sold the skin rejuvenation devices, we were required pay Dr. Zumeris $5,000 per unit
an aggregate amount of $100,000 has been paid to Dr. Zumeris.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018, Dr. Zumeris exercised options under $4.45 a share; and the Company did not record a liability for this transaction
in 2019. During the year ended December 31, 2018, the Company incurred expenses of $108,000 associated with the Separation Agreement.
During the year ended December 31, 2019, the Company incurred expenses of $37,000 associated with the Separation Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 17, 2019, a lawsuit was filed by a former officer and director, Jona Zumeris, in the Haifa Israel District Financial Court,
seeking damages of approximately $900,000 for breach of the Separation Agreement executed on July 4, 2018. In January 2021, the parties
reached a settlement in which the Company paid the plaintiff approximately $366,000 as settlement in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>ITEM
14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees
to Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the fees billed to us by Marcum LLP for the year ended December 31, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2020</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Audit fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">170,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">208,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Audit-related fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">All other fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,725</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">109.000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">177,725</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">317,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit
Fees</i>. This category includes the fees related to the audit of our annual financial statements and the review of our interim quarterly
financial statements and services that are normally provided by our independent registered public accounting firm in connection with
its engagements for those years. This category also includes advice on audit and accounting matters that arose during, or as a result
of, the audit or the review of our interim financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit-Related
Fees. </i>This category typically consists of assurance and related services by our independent registered public accounting firm that
are reasonably related to the performance of the audit or review of our financial statements and are not reported above under &#8220;Audit
Fees.&#8221; The services for the fees disclosed under this category include consents regarding equity issuances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
Fees</i>. This category typically consists of professional services rendered by our independent registered public accounting firm for
tax compliance and tax advice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>All
Other Fees</i>. This category includes aggregate fees billed in each of the last two fiscal years for products and services provided
by Marcum LLC other than the services reported in the categories above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-Approval
Policies and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the audit committee&#8217;s pre-approval policies and procedures, the audit committee is required to pre-approve the audit and non-audit
services performed by our independent registered public accounting firm. On an annual basis, the audit committee pre-approves a list
of services that may be provided by the independent registered public accounting firm without obtaining specific pre-approval from the
audit committee. In addition, the audit committee sets pre-approved fee levels for each of the listed services. Any type of service that
is not included on the list of pre-approved services must be specifically approved by the audit committee or its designee. Any proposed
service that is included on the list of pre-approved services but will cause the pre-approved fee level to be exceeded will also require
specific pre-approval by the audit committee or its designee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee has delegated pre-approval authority to the audit committee chairman and any pre-approved actions by the audit committee
chairman as designee are reported to the audit committee for approval at its next scheduled meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the services rendered by Marcum LLC were pre-approved by the audit committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board considered the audit fees, audit-related fees, tax fees and other fees paid to our accountants, as disclosed above, and determined
that the payment of such fees was compatible with maintaining the independence of the accountants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_001"></span>PART
IV</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_002"></span>ITEM
15. EXHIBITS, AND FINANCIAL STATEMENT SCHEDULES.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The following exhibits are filed as part of this Amendment No. 1 to Annual Report on Form 10-K:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415023396/v407400_ex3-1.htm" style="-sec-extract: exhibit">Amended and Restated Certificate of Incorporation (as presently in effect) (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on April 17, 2015)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420414026177/v376141_ex3-2.htm" style="-sec-extract: exhibit">Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to Amendment No. 3 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 30, 2014)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420414026177/v376141_ex3-3.htm" style="-sec-extract: exhibit">Certificate of Amendment of Certificate of Incorporation (creating the Series C Preferred Stock) (incorporated by reference to Exhibit 3.3 to Amendment No. 3 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 30, 2014)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577417006323/s108034_ex3-1.htm" style="-sec-extract: exhibit">Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on November 7, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000121390019024108/f10q0919ex4-1_nanovibronix.htm" style="-sec-extract: exhibit">Certificate of Designation, Preferences, Rights and Limitations of Series E Preferred Stock (incorporated by reference to Exhibit 4.1 to the Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 19, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000121390019024350/f8k111819ex3-1_nanovibronix.htm" style="-sec-extract: exhibit">Certificate of Amendment of the Amended and Restated Certificate of Designation (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 21, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315221028715/ex3-7.htm" style="-sec-extract: exhibit">Certificate of Amendment of Certificate of Incorporation (incorporated by reference to Exhibit 3.7 to the Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 15, 2021)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315221027166/ex3-1.htm" style="-sec-extract: exhibit">Amendment to the Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on November 3, 2021)</a>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420414013884/v370657_ex4-2.htm" style="-sec-extract: exhibit">Form of Common Stock Certificate (incorporated by reference to Exhibit 4.2 to Amendment No. 1 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on March 6, 2014)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577417006088/s107929_ex4-4.htm" style="-sec-extract: exhibit">Form of Warrant Agency Agreement (incorporated by reference to Exhibit 4.4 to Amendment No. 4 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on October 31, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577417005758/s107716_ex4-3.htm" style="-sec-extract: exhibit">Form of Unit Purchase Option (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on October 18, 2017)</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577417005758/s107716_ex4-2.htm" style="-sec-extract: exhibit">Form of Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.2 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on October 18, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577419008162/s118351_ex4-1.htm" style="-sec-extract: exhibit">Form of May 10 and May 15, 2019 Warrants (incorporated by reference to Exhibit 4.1 to the Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 20, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000121390019011522/f8k062119ex4-2_nanovibronix.htm" style="-sec-extract: exhibit">Form of Warrant (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 26, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000121390019014211/f8k073119ex4-2_nanovibro.htm" style="-sec-extract: exhibit">Form of Preferred Warrant (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on July 31, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000121390019014211/f8k073119ex4-3_nanovibro.htm" style="-sec-extract: exhibit">Form of Common Warrant (incorporated by reference to Exhibit 4.3 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on July 31, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220009519/ex4-10.htm" style="-sec-extract: exhibit">Form of Warrant Amendment (incorporated by reference to Exhibit 4.10 to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 20, 2020)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220016774/ex4-1.htm" style="-sec-extract: exhibit">Form of Underwriter Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on August 26, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220018277/ex4-1.htm" style="-sec-extract: exhibit">Form of Underwriter Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on September 24, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220023054/ex4-1.htm" style="-sec-extract: exhibit">Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on December 7, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220023054/ex4-2.htm" style="-sec-extract: exhibit">Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on December 7, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315222009985/ex4-14.htm" style="-sec-extract: exhibit">Description
    of Securities (incorporated by reference to Exhibit 4.14 to the Annual Report on Form 10-K filed with the Securities and Exchange
    Commission on April 15, 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415007032/v400364_ex10-9.htm" style="-sec-extract: exhibit">Fourteenth Amended and Restated Securities Purchase Agreement, dated June 16, 2014, by and between NanoVibronix, Inc. and Globis Overseas Fund, Ltd. (incorporated by reference to Exhibit 10.9 to the Registration Statement on Form 10 filed with the Securities and Exchange Commission on February 9, 2015)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415007032/v400364_ex10-10.htm" style="-sec-extract: exhibit">Fourteenth Amended and Restated Securities Purchase Agreement, dated December 11, 2014, by and between NanoVibronix, Inc. and Globis Capital Partners, L.P. (incorporated by reference to Exhibit 10.10 to the Registration Statement on Form 10 filed with the Securities and Exchange Commission on February 9, 2015)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415007032/v400364_ex10-11.htm" style="-sec-extract: exhibit">Fifteenth Amended and Restated Secured Convertible Promissory Note, dated December 11, 2014, by NanoVibronix, Inc. in favor of and Globis Overseas Fund, Ltd. (incorporated by reference to Exhibit 10.11 to the Registration Statement on Form 10 filed with the Securities and Exchange Commission on February 9, 2015)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415007032/v400364_ex10-12.htm" style="-sec-extract: exhibit">Fifteenth Amended and Restated Secured Convertible Promissory Note, dated December 11, 2014, by NanoVibronix, Inc. in favor of and Globis Capital Partners, L.P. (incorporated by reference to Exhibit 10.12 to the Registration Statement on Form 10 filed with the Securities and Exchange Commission on February 9, 2015)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420414017621/v372463_ex10-13.htm" style="-sec-extract: exhibit">Form of Amended and Restated 2013 and 2014 Warrant to Purchase Common Stock (incorporated by reference to Exhibit 10.13 to Amendment No. 2 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on March 25, 2014)</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420414013884/v370657_ex10-14.htm" style="-sec-extract: exhibit">NanoVibronix, Inc. 2004 Global Share Option Plan (incorporated by reference to Exhibit 10.14 to Amendment No. 1 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on March 6, 2014)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420414013884/v370657_ex10-15.htm" style="-sec-extract: exhibit">Personal Employment Agreement, dated March 1, 2008, by and between Nano-Vibronix (Israel 2003) Ltd and Jona Zumeris (incorporated by reference to Exhibit 10.15 to Amendment No. 1 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on March 6, 2014)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420414013884/v370657_ex10-16.htm" style="-sec-extract: exhibit">Form of Indemnification Agreement between NanoVibronix, Inc. and certain of its officers and directors (incorporated by reference to Exhibit 10.16 to Amendment No. 1 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on March 6, 2014)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420414013884/v370657_ex10-17.htm" style="-sec-extract: exhibit">Amendment to Subscription Agreement Convertible Promissory Notes, dated February 28, 2014, by and between NanoVibronix, Inc. and the note holders signatory thereto (incorporated by reference to Exhibit 10.17 to Amendment No. 1 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on March 6, 2014)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420414013884/v370657_ex10-19.htm" style="-sec-extract: exhibit">Second Amendment to Subscription Agreement Series B Convertible Preferred Stock and Warrants), dated February 28, 2014, by and between NanoVibronix, Inc. and the holders signatory thereto (incorporated by reference to Exhibit 10.19 to Amendment No. 1 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on March 6, 2014)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420414013884/v370657_ex10-20.htm" style="-sec-extract: exhibit">Third Amendment to Subscription Agreement Series B Convertible Preferred Stock and Warrants), dated February 28, 2014, by and between NanoVibronix, Inc. and the holders signatory thereto (incorporated by reference to Exhibit 10.20 to Amendment No. 1 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on March 6, 2014)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420414026177/v376141_ex10-27.htm" style="-sec-extract: exhibit">NanoVibronix, Inc. 2014 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.27 to Amendment No. 3 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 30, 2014)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420414039017/v381244_ex10-29.htm" style="-sec-extract: exhibit">First Amendment to Personal Employment Agreement, dated June 16, 2014, by and between NanoVibronix, Inc. and Dr. Jona Zumeris (incorporated by reference to Exhibit 10.29 to Amendment No. 8 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on June 23, 2014)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415019323/v405877_ex10-35.htm" style="-sec-extract: exhibit">Services Agreement, dated March 25, 2015, by and between Multigon Industries, Inc. and NanoVibronix, Inc. (incorporated by reference to Exhibit 10.35 to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2015)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415019323/v405877_ex10-36.htm" style="-sec-extract: exhibit">Employment Agreement, dated March 25, 2015, by and between William Stern and NanoVibronix, Inc. (incorporated by reference to Exhibit 10.36 to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2015)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415019323/v405877_ex10-38.htm" style="-sec-extract: exhibit">Warrant to Purchase Common Stock, dated March 25, 2015 (incorporated by reference to Exhibit 10.38 to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2015)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415019323/v405877_ex10-39.htm">Letter Agreement, dated March 25, 2015, by and between NanoVibronix, Inc. and Martin Goldstein (incorporated by reference to Exhibit 10.39 to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2015)</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415019323/v405877_ex10-40.htm" style="-sec-extract: exhibit">Form of Incentive Stock Option Award Agreement under the 2014 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.40 to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2015)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415019323/v405877_ex10-41.htm" style="-sec-extract: exhibit">Form of Nonqualified Stock Option Award Agreement under the 2014 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.41 to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2015)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415019323/v405877_ex10-42.htm" style="-sec-extract: exhibit">Form of Restricted Stock Award Agreement under the 2014 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.42 to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2015)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415019323/v405877_ex10-43.htm" style="-sec-extract: exhibit">Form of 3(i) Award Agreement under the Israeli Appendix to the 2014 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.43 to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2015)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420415019323/v405877_ex10-44.htm" style="-sec-extract: exhibit">Form of 102 Award Agreement under the Israeli Appendix to the 2014 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.44 to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2015)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420416128601/v450779_ex10-3.htm" style="-sec-extract: exhibit">Employment Agreement, dated October 13, 2016, by and between NanoVibronix, Inc. and Brian Murphy (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on October 19, 2016)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420417018057/v462181_ex10-46.htm" style="-sec-extract: exhibit">Form of Amendment to Warrant to Purchase Common Stock, effective as of January 27, 2017 (incorporated by reference to Exhibit 10.46 to the Annual Report on Form 10-K filed with the Securities Exchange Commission on March 31, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420417013197/v461321_ex10-1.htm" style="-sec-extract: exhibit">Form of Convertible Promissory Note (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on March 7, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420417013197/v461321_ex10-2.htm" style="-sec-extract: exhibit">Form of Warrant to Purchase Common Stock (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on March 7, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420417016715/v462688_ex10-1.htm" style="-sec-extract: exhibit">Convertible Promissory Note, dated March 23, 2017, by and between NanoVibronix, Inc. and an individual investor (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on March 27, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420417016715/v462688_ex10-2.htm" style="-sec-extract: exhibit">Warrant to Purchase Common Stock, dated March 23, 2017, by and between NanoVibronix, Inc. and an individual investor (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on March 27, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420417018057/v462181_ex10-51.htm" style="-sec-extract: exhibit">First Amendment to Nonqualified Stock Option Agreement, dated March 30, 2017, between NanoVibronix, Inc. and Ira A. Greenstein (incorporated by reference to Exhibit 10.51 to the Annual Report on Form 10-K filed with the Securities Exchange Commission on March 31, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420417018057/v462181_ex10-52.htm" style="-sec-extract: exhibit">First Amendment to Nonqualified Stock Option Agreement, dated March 30, 2017, between NanoVibronix, Inc. and Ira A. Greenstein (incorporated by reference to Exhibit 10.52 to the Annual Report on Form 10-K filed with the Securities Exchange Commission on March 31, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420417018057/v462181_ex10-52.htm" style="-sec-extract: exhibit">Offer Letter, dated October 14, 2016, between NanoVibronix, Inc. and Christopher M. Fashek (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on October 19, 2016)</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420416128601/v450779_ex10-2.htm" style="-sec-extract: exhibit">Nonqualified Stock Option Agreement, dated October 14, 2016, between NanoVibronix, Inc. and Christopher M. Fashek (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on October 19, 2016)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.33</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420417024725/v466226_ex10-1.htm" style="-sec-extract: exhibit">Form of Convertible Promissory Note (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on May 5, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.34</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420417024725/v466226_ex10-2.htm" style="-sec-extract: exhibit">Form of Warrant to Purchase Common Stock (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on May 5, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.35</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577417005081/s107502_ex10-1.htm" style="-sec-extract: exhibit">Form of Letter Agreement, dated September 7, 2017, between NanoVibronix, Inc. and holders of the 2017 Notes (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K/A filed with the Securities and Exchange Commission on September 14, 2017)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.36</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577419005785/s116899_ex10-36.htm" style="-sec-extract: exhibit">Consulting Agreement dated as of February 21, 2019, between NanoVibronix, Inc and Bespoke Growth Partners, Inc. (incorporated by reference to Exhibit 10.36 to the Annual Report on Form 10-K/A filed with the Securities and Exchange Commission on May 13, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.37</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577419005785/s116899_ex10-37.htm" style="-sec-extract: exhibit">Convertible Promissory Note (incorporated by reference to Exhibit 10.37 to the Annual Report on Form 10-K/A filed with the Securities and Exchange Commission on May 13, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.38</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577419005785/s116899_ex10-38.htm" style="-sec-extract: exhibit">Convertible Promissory Note (incorporated by reference to Exhibit 10.38 to the Annual Report on Form 10-K/A filed with the Securities and Exchange Commission on May 13, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.39</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577419005785/s116899_ex10-39.htm" style="-sec-extract: exhibit">Form of Warrant (incorporated by reference to Exhibit 10.39 to the Annual Report on Form 10-K/A filed with the Securities and Exchange Commission on May 13, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.40</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577419008162/s118351_ex10-1.htm" style="-sec-extract: exhibit">Convertible Promissory Note (Globis), May 10, 2019 (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 20, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.41</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577419009203/s118829_ex10-1.htm" style="-sec-extract: exhibit">Convertible Promissory Note (AiGH), May 15, 2019 (incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 20, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.42+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577419009203/s118829_ex10-1.htm" style="-sec-extract: exhibit">CFO Consulting Agreement, dated as of June 1, 2019, between NanoVibronix Inc. and James S. Cardwell (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 4, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.43</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000121390019011522/f8k062119ex10-1_nanovibronix.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated as of June 21, 2019, by and among the Company and each investor identified on the signature pages thereto (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 26, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.44</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000121390019014211/f8k073119ex10-1_nanovibro.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated as of July 31, 2019, by and among the Company and each investor identified on the signature pages thereto (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on July 31, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.45</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000121390019014211/f8k073119ex10-2_nanovibro.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated as of July 31, 2019, by and among the Company and each investor identified on the signature pages thereto (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on July 31, 2019)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.46</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220011864/ex10-1.htm" style="-sec-extract: exhibit">Form of Note (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 26, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.47</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220011864/ex10-2.htm" style="-sec-extract: exhibit">Form of Warrant (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 26, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.48</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220016309/ex10-3.htm" style="-sec-extract: exhibit">Note with Cross River Bank (SBA-Payroll Protection Program loan) dated May 14, 2020 (incorporated by reference to Exhibit 10.3 to the Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 19, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.49+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220019127/ex10-1.htm" style="-sec-extract: exhibit">Employment Agreement, dated as of October 5, 2020, between NanoVibronix, Inc. and Stephen Brown (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on October 8, 2020).</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.50+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220020509/ex10-1.htm" style="-sec-extract: exhibit">Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Brian Murphy (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 5, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.51+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220020509/ex10-2.htm" style="-sec-extract: exhibit">Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Christopher Fashek (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 5, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.52+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220020509/ex10-3.htm" style="-sec-extract: exhibit">Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Martin Goldstein (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 5, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.53+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220020509/ex10-4.htm" style="-sec-extract: exhibit">Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Michael Ferguson (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 5, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.54+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220020509/ex10-5.htm" style="-sec-extract: exhibit">Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Stephen Brown (incorporated by reference to Exhibit 10.5 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 5, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.55+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220020509/ex10-6.htm" style="-sec-extract: exhibit">Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Thomas Mika (incorporated by reference to Exhibit 10.6 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 5, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.56</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220023054/ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement, dated December 2, 2020 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on December 7, 2020)</a>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.57</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315220023054/ex10-2.htm" style="-sec-extract: exhibit">Form of Registration Rights Agreement, dated December 2, 2020 (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on December 7, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.58#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315221008951/ex10-58.htm" style="-sec-extract: exhibit">Amended and Restated Distribution Agreement for &#8220;Private Labeled&#8221; Products dated December 10, 2020 by and between NanoVibronix, Inc. and Ultra Pain Products Inc (incorporated by reference to Exhibit 10.58 to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 15, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.59+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000161577419006754/s117834_def14a.htm#a027_v1" style="-sec-extract: exhibit">Second Amendment to the NanoVibronix, Inc. 2014 Long-Term Incentive Plan. (incorporated by reference to Annex A to the Company&#8217;s definitive proxy statement on Schedule 14A filed with the SEC on April 30, 2019).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.60+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315221032899/ex10-1.htm" style="-sec-extract: exhibit">Third Amendment to the Nanovibronix, Inc. 2014 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on December 30, 2021).</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.61+*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-61.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement, dated January 1, 2022, by and between NanoVibronix, Inc. and Brian Murphy</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.62+*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-62.htm">Employment Agreement, dated January 1, 2022, by and between NanoVibronix, Inc. and Stephen Brown.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000114420414013884/v370657_ex21-1.htm" style="-sec-extract: exhibit">List of Subsidiaries (incorporated by reference to Exhibit 21.1 to Amendment No. 1 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on March 6, 2014)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315222009985/ex23-1.htm" style="-sec-extract: exhibit">Consent of Marcum, LLP, Independent Registered Public Accounting Firm (Previously filed with the Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 15, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315222009985/ex31-1.htm" style="-sec-extract: exhibit">Certification of Chief Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002 (Previously filed with the Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 15, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315222009985/ex31-2.htm" style="-sec-extract: exhibit">Certification of Chief Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002 (Previously filed with the Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 15, 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.3*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex31-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.4*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex31-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315222009985/ex32-1.htm" style="-sec-extract: exhibit">Certification of Chief Executive Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Previously furnished with the Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 15, 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1326706/000149315222009985/ex32-2.htm" style="-sec-extract: exhibit">Certification of Chief Financial Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Previously furnished with the Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 15, 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    following materials from the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021, formatted in Inline
    XBRL <span style="text-decoration: underline"></span>(eXtensible
    Business Reporting Language), (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Comprehensive Loss, (iii) Consolidated
    Statements of Changes in Stockholders&#8217; Deficiency, (iv) Consolidated Statements of Cash Flows, and (v) Notes to the Consolidated
    Financial Statements (Previously filed with the Annual Report on Form 10-K filed with the Securities and Exchange Commission on
    April 15, 2022)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    contract or compensatory plan or arrangement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    portions of this exhibit have been redacted pursuant to Item 601(b)(10) of Regulation S-K. The omitted information is (i) not material
    and (ii) would likely cause competitive harm to the Company if publicly disclosed. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 28; Value: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_007"></span>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NANOVIBRONIX, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    May 2, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Brian
    Murphy</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Murphy</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 29; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjVEKwkAMRE/QO4T9ltquitI/LSpiFSki/i42lcV2U7Jr1SN5S9cWMQRCmHkzQgzEmla6QobzIs/giHVTKYeQY4mM5oLekW62Cfib41Vbx8q47v2BKXkGPTMJ45HyQmdttcUigWg8lNOhlBDNkskM5jsRfPWUTKkLNE6rCpQp4MDUsEan+NUnHNWTDNWvruqEbDWZBOIw6uU3yCiWsKdWPYhvFrIsFcGgm0Csme7Nt+ZuHdWwrLD2XbZH/xt8ABbiSUc= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.61
<SEQUENCE>2
<FILENAME>ex10-61.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
10.61</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EMPLOYMENT
AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
EMPLOYMENT AGREEMENT </B>(this &ldquo;<B><I>Agreement</I></B>&rdquo;) is dated as of January 1, 2022 (the <I>&ldquo;<B>Effective Date</B>&rdquo;</I>)
and is entered into by and between Brian Murphy (the &ldquo;<B><I>Executive</I></B>&rdquo;) and NanoVibronix, Inc. (the &ldquo;<B><I>Company</I></B>&rdquo;).
The Company and the Executive shall be referred to herein as the &ldquo;<B><I>Parties</I></B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Executive is presently serving as the Chief Executive Officer (&ldquo;CEO&rdquo;) of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company and the Executive mutually desire to memorialize the terms and conditions under which the Executive will continue to serve
as the CEO of the COMPANY;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company hereby employs the Executive, and the Executive hereby accepts employment as the CEO of the Company for the period and subject
to the terms and conditions contained in this Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company and the Executive are parties to a certain Stock Options Purchase Agreement that, among other things, affects the Parties&rsquo;
existing and continued employment relationship and contains certain conditions and limitations on the Executive&rsquo;s right to purchase
a portion of the Company&rsquo;s capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the mutual promises and agreements contained herein, and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the Parties hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>DEFINITIONS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Term</B>&rdquo;
    </I>refers to the period during which the Executive is employed by the Company as the Company&rsquo;s CEO under this Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Confidential
    Information</B>&rdquo; </I>includes any trade secrets or confidential or proprietary information of the Company, including, but not
    limited to, the following: methods of operation, products, inventions, services, processes, equipment, know-how, technology, technical
    data, policies, strategies, designs, formulas, developmental or experimental work, improvements, discoveries, research, plans for
    research or future products and services, database schemas or tables, software, development tools or techniques, training procedures,
    training techniques, training manuals, business information, marketing and sales methods, plans and strategies, competitors, markets,
    market surveys, techniques, production processes, infrastructure, business plans, distribution and installation plans, processes
    and strategies, methodologies, budgets, financial data and information, customer and client information, prices and costs, fees,
    customer and client lists and profiles, employee, customer and client nonpublic personal information, supplier lists, business records,
    product construction, product specifications, audit processes, pricing strategies, business strategies, marketing and promotional
    practices, management methods and information, plans, reports, recommendations and conclusions, information regarding the skills
    and compensation of employees and contractors of the Company, and other business information disclosed to the Executive by the Company,
    either directly or indirectly, in writing, orally, or by drawings or observation. <I>&ldquo;<B>Confidential Information</B>&rdquo;
    </I>does not include, and there shall be no obligation hereunder with respect to, information that (i) is generally available to
    the public on the date of this Agreement or (ii) becomes generally available to the public other than as a result of a disclosure
    not otherwise permissible hereunder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Cause</B>,&rdquo;
    </I>as used herein in reference to termination of the Executive&rsquo;s employment with the Company, shall mean the Executive&rsquo;s
    (a) intentional and material dishonesty in the performance of the Executive&rsquo;s duties for the Company, including any acts of
    theft, embezzlement, or fraud; (b) indictment or conviction of, or pleading nolo contendere or guilty to, a felony or a crime involving
    moral turpitude; (c) refusal to perform, or intentional disregard of, in any material respect, the Executive&rsquo;s duties and responsibilities
    under this Agreement; and (d) incurable material breach of this Agreement or any other agreement to which the Executive and the Company
    are parties. In each such event listed above, if the circumstances are curable, the Company shall give the Executive written notice
    thereof which shall specify in reasonable detail the circumstances constituting Cause, and there shall be no Cause with respect to
    any such circumstances if cured by the Executive within thirty (30) days after such notice.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Good
    Reason</B>,&rdquo; </I>as used herein in reference to termination of the Executive&rsquo;s employment with the Company, shall mean:
    (a) any material reduction, without the Executive&rsquo;s consent, in the Executive&rsquo;s duties or responsibilities; (b) a material
    breach by the Company of this Agreement or any other agreement to which the Executive and the Company are parties; (c) any material
    reduction in the Executive&rsquo;s then current base salary plus target bonus opportunity compensation; or (d) any requirement that
    the Executive relocate or spend more than 50% of the next fiscal year in a location more than 50 miles from his current place of
    residence. In each such event listed above, the Executive shall give the Company written notice thereof which shall specify in reasonable
    detail the circumstances constituting Good Reason, and there shall be no Good Reason with respect to any such circumstances if cured
    by the Company within thirty (30) days after such notice.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Change
    in Control</B>&rdquo; </I>shall mean: (a) any merger, acquisition or similar transaction or series of related transactions in which
    the Company is not the surviving entity, except for a transaction the principal purpose of which is to change the jurisdiction in
    which the Company is incorporated; (b) the sale, transfer or other disposition of all or substantially all of the assets of the Company;
    or (c) any reverse merger or acquisition in which the Company is the surviving entity but in which more than fifty percent (50%)
    of the Company&rsquo;s outstanding voting stock is transferred to holders different from those who held the stock immediately prior
    to such merger.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Restricted
    Period</B>&rdquo; </I>means during the Executive&rsquo;s employment with the Company and for a period of twelve (12) months immediately
    following the date of termination of Executive&rsquo;s employment with the Company for any reason.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 41.95pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>G.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Competing
    Business</B>&rdquo; </I>means any business, individual, partnership, firm, corporation or other entity that is competing with any
    aspect of the Company&rsquo;s business.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>H.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Work
    Product</I></B>&rdquo; shall mean, collectively, all work product, information, inventions, original works of authorship, ideas,
    know-how, processes, designs, computer programs, photographs, illustrations, developments, trade secrets and discoveries, including
    improvements thereto, that the Executive conceives, creates, develops, makes, reduces to practice, or fixes in a tangible medium
    of expression, either alone or with others.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SERVICES
TO BE PROVIDED BY EXECUTIVE</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Position
    and Responsibilities</U>. </B>The Executive shall be employed and serve as the CEO of the Company (together with such other position
    or positions consistent with the Executive&rsquo;s title as the Board of Directors (the &ldquo;<B><I>Board</I></B>&rdquo;) shall
    specify from time to time) and shall report directly to the Board. The Executive shall have such duties and responsibilities commensurate
    with such title, and as the Board may require of the Executive from time to time. The Executive also agrees to serve, if elected,
    as an officer or director of the Company or any other affiliate of the Company, in each such case at no compensation in addition
    to that provided for in this Agreement. The Company will use its best efforts to cause the Executive to be elected as a member of
    the Board as long as the Executive continues to serve as the CEO. Should the Executive&rsquo;s employment terminate for any reason,
    the Executive shall resign as a member of the Board.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Performance</U>.
    </B>The Executive shall devote, for the number of hours and during the times mutually agreed to by the parties, the Executive&rsquo;s
    time, energy, skill and reasonable best efforts to the performance of the Executive&rsquo;s duties hereunder in a manner that will
    faithfully and diligently further the business and interests of the Company, and shall exercise reasonable best efforts to perform
    the Executive&rsquo;s duties in a diligent, trustworthy, good faith and business-like manner, all for the purpose of advancing the
    business of the Company. The Executive shall at all times act in a manner consistent with Executive&rsquo;s position as CEO.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Compliance</U>.
    </B>In the performance of the Executive&rsquo;s duties hereunder and as the CEO of the Company, the Executive agrees to act in accordance
    with high business and ethical standards at all times. The Executive shall comply with policies, codes of conduct, codes of ethics,
    written manuals and lawful directives of the Company and any of its affiliates. The Executive shall keep the Board promptly and fully
    informed of the Executive&rsquo;s conduct in connection with the business affairs of the Company. The Executive shall report to the
    Board the Executive&rsquo;s own wrongdoing and any wrongdoing or proposed wrongdoing of any other employee, director, affiliate or
    contractor of the Company or other person performing services on behalf of or for the Company immediately upon becoming aware of
    it.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>COMPENSATION
FOR SERVICES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
compensation for all services the Executive will perform under this Agreement, the Company shall pay the Executive, and the Executive
shall accept as full compensation, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Base
    Salary</U>. </B>The Company shall pay the Executive an annual salary of <B><U>$300,000 (USD)</U></B>, less any applicable payroll
    deductions and tax withholdings (the &ldquo;<B><I>Base Salary</I></B>&rdquo;), for all services rendered by the Executive under this
    Agreement. The Company shall pay the Executive the Base Salary in accordance with standard payroll practices of the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Performance
    Bonus</U>.</B> During each year of the Term, the Executive shall be eligible to receive an annual bonus (<I>&ldquo;<B>Performance
    Bonus</B>&rdquo;</I>) of up to <B><U>$100,000 (USD)</U></B>, less applicable payroll deductions and tax withholdings. The Performance
    Bonus shall be based on the extent to which the Executive has met performance criteria for the year, as determined in good faith
    by the Board or the Compensation Committee of the Board, and be paid within thirty (30) days of the Company&rsquo;s issuance of its
    audited financial statements for that year on Form 10-K (in the calendar year following the calendar year to which the Performance
    Bonus relates).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Stock
    Options</U>. </B>The Executive has received, and may be eligible to receive, certain grants of incentive stock options to purchase
    shares of common stock of the Company (the <I>&ldquo;<B>Stock Options</B>&rdquo;</I>) set forth separately in the certain Stock Options
    Purchase Agreement(s).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Expenses</U>.
    </B>The Company agrees that, during the Executive&rsquo;s employment, it will reimburse the Executive for out-of-pocket expenses
    reasonably incurred in connection with the Executive&rsquo;s performance of the Executive&rsquo;s services hereunder, upon the presentation
    by the Executive of an itemized accounting of such expenditures, with supporting receipts. Reimbursements shall be in compliance
    with the Company&rsquo;s expense reimbursement policies.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Vacation</U>.
    </B>The Executive shall be eligible for four (4) weeks paid vacation in accordance with the Company&rsquo;s policy in effect from
    time to time.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Other
    Benefits</U>. </B>The Executive is entitled to participate in any group health insurance plan, 401(k) plan, disability plan, group
    life plan, and any other benefit or welfare program or policy that is made generally available, from time to time, to other employees
    of the Company, on a basis consistent with such participation and subject to the terms of the plan documents, as such plans may be
    modified, amended, terminated, or replaced from time to time. Notwithstanding anything to the contrary contained herein, in the event
    that the Company does not have a group health plan on the Effective Date and the Executive (and his eligible dependents) elect to
    continue group health plan coverage under the Executive&rsquo;s prior employer&rsquo;s group health plan in accordance with the Consolidated
    Omnibus Budget Reconciliation Act of 1985, as amended (&ldquo;COBRA&rdquo;), the Company agrees to pay or reimburse the Executive
    for 100% of the premiums due with respect to such COBRA coverage upon presentation by the Executive to the Company of a statement
    of premiums due with respect to such coverage, from the Effective Date until the earliest of: (i) the date the Executive and his
    eligible dependents are eligible for coverage under a group health plan of the Company; (ii) the end of the Term; or (iii) the date
    the Executive&rsquo;s COBRA coverage terminates for any reason (other than non-payment of premiums).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>G.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Code
    Section 409A</U>.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    the extent (a) any payments to which the Executive becomes entitled under this Agreement, or any agreement or plan referenced herein,
    in connection with the termination of Executive&rsquo;s employment with the Company or the Executive&rsquo;s separation from service
    to the Company constitute deferred compensation subject to Section 409A of the Internal Revenue Code of 1986 as amended (the &ldquo;Code&rdquo;);
    (b) the Executive is deemed at the time of his termination/separation to be a &ldquo;specified employee&rdquo; under Section 409A
    of the Code; and (c) at the time of the Executive&rsquo;s termination, the Company is publicly traded (as defined in Section 409A
    of the Code), then such payments (other than any payments permitted by Section 409A of the Code to be paid within six (6) months
    of the Executive&rsquo;s termination/separation) shall not be made until the earlier of (1) the first day of the seventh month following
    the Executive&rsquo;s termination/separation, or (2) the date of the Executive&rsquo;s death following such termination/separation.
    Upon the expiration of the applicable deferral period, any payments which would have otherwise been made during that period (whether
    in a single lump sum or in installments) in the absence of this <U>Article III</U> shall be paid to the Executive or the Executive&rsquo;s
    beneficiary in one lump sum, plus interest thereon, at the Delayed Payment Interest Rate (as defined below) computed from the date
    on which each such delayed payment otherwise would have been made to the Executive until the date of payment. For purposes of the
    foregoing, the <I>&ldquo;<B>Delayed Payment Interest Rate</B>&rdquo; </I>shall mean the national average annual rate of interest
    payable on jumbo six-month bank certificates of deposit, as quoted in the business section of the most recently published Sunday
    edition of The New York Times preceding the date of termination of the Executive&rsquo;s employment with the Company or the Executive&rsquo;s
    separation from service to the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    the extent any benefits provided under <U>Article III</U> above are otherwise taxable to the Executive, such benefits shall, for
    purposes of Section 409A of the Code, be provided as separate in-kind payments of those benefits, and the provision of in-kind benefits
    during one calendar year shall not affect the in-kind benefits to be provided in any other calendar year.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the case of any amounts payable to the Executive under this Agreement, or under any plan of the Company, that may be treated as payable
    in the form of &ldquo;a series of installment payments,&rdquo; as defined in Treas. Reg. &sect;l.409A-2(b)(2)(iii), the Executive&rsquo;s
    right to receive such payments shall be treated as a right to receive a series of separate payments for purposes of Treas. Reg. &sect;l.409A-2(b)(2)(iii).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
    is intended that this Agreement comply with or be exempt from the provisions of Section 409A of the Code and the Treasury Regulations
    and guidance of general applicability issued thereunder, and in furtherance of this intent, this Agreement shall be interpreted,
    operated, and administered in a manner consistent with such intent.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 119.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>TERM
&amp; TERMINATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Term
    of Employment</U>. </B>The Term of the Executive&rsquo;s employment under this Agreement shall continue in effect until the second
    anniversary of the Effective Date, unless earlier terminated by either party in accordance with this <U>Article IV</U>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination</U>.
    </B>Either Party may terminate the Executive&rsquo;s employment with the Company at any time upon 90 days written notice to the other
    Party, with the date of termination of the Executive&rsquo;s employment with the Company being the date provided in the notice of
    termination. Upon termination of the Executive&rsquo;s employment, the Company shall pay the Executive: (i) any earned but unpaid
    Performance Bonus for the calendar year prior to the calendar year in which the Executive&rsquo;s termination occurs, with payment
    of such Performance Bonus being due within the earlier of the time period specified in <U>Article III, Section B</U> or as specified
    in this <U>Article IV, Section B</U>; (ii) any accrued and unpaid vacation or similar pay to which the Executive is entitled as a
    matter of law or Company policy; and (iii) any unreimbursed expenses properly incurred prior to the date of termination (the &ldquo;<B><I>Accrued
    Obligations</I></B>&rdquo;). The Accrued Obligations shall be payable in a lump sum within the time period required by applicable
    law, and in no event later than thirty (30) days following the date of termination of the Executive&rsquo;s employment. Except for
    the Accrued Obligations and any other payments owed pursuant to the applicable scenarios in <U>Sections 1-3</U> below, upon termination
    of the Executive&rsquo;s employment, the Company shall have no further liability or obligations to the Executive in connection with
    the Executive&rsquo;s employment under this Agreement. The Executive&rsquo;s termination of employment under this Agreement shall
    also constitute the Executive&rsquo;s resignation as an officer or director of any affiliate or subsidiary of the Company, as applicable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination
    for Cause or Resignation Without Good Reason</U>. </B>In the event the Company terminates the Executive&rsquo;s employment for Cause
    (defined below), or the Executive voluntarily resigns without Good Reason (defined below), the Company shall have no further liability
    or obligation to the Executive under this Agreement or in connection with the Executive&rsquo;s employment hereunder, except for
    the Accrued Obligations. The Accrued Obligations shall be payable in a lump sum within the time period required by applicable law,
    and in no event later than thirty (30) days following the date of the Executive&rsquo;s termination.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination
    Without Cause or Resignation For Good Reason</U>. </B>In the event the Executive&rsquo;s employment is terminated by the Company
    without Cause or by the Executive for Good Reason, and subject to the Executive releasing the Company from claims by executing and
    timely returning a form provided by the Company, which form shall be irrevocable no later than sixty (60) days following the date
    of the Executive&rsquo;s termination of employment, the Executive shall receive the following: (a) any Accrued Obligations, payable
    in a lump sum within the time period required by applicable law, and in no event later than thirty (30) days following the date of
    termination of the Executive&rsquo;s employment with the Company; (b) severance pay in an amount equal to the Executive&rsquo;s Base
    Salary for twelve (12) months (the <I>&ldquo;<B>Severance Period</B>&rdquo;</I>) plus the full amount of the Performance Bonus for
    the year in which the termination of the Executive occurs, payable either as a lump sum within the same time period as the Accrued
    Obligations or in equal installments in accordance with the Company&rsquo;s standard payroll policies, with the first installment
    being paid no later than sixty (60) days following the Company&rsquo;s first regular payment date following the date of the Executive&rsquo;s
    termination, in which event such first payment shall include all installments that would otherwise already have been paid to the
    Executive during the period of up to sixty (60) days following the Executive&rsquo;s termination had payments of the installments
    commenced immediately following the date of the Executive&rsquo;s termination; (c) an additional lump sum payment equivalent to the
    Company&rsquo;s portion of the premium payable under the Company&rsquo;s health insurance benefits and sufficient to cover twelve
    (12) months of COBRA coverage for the Executive, such amount be paid on the Company&rsquo;s first regular pay date no later than
    on the sixtieth (60th) day following the date of the Executive&rsquo;s termination.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination
    Following a Change In Control</U>.</B> In the event that, following a Change in Control, the Executive&rsquo;s employment is terminated
    by the Company (or its successor) without Cause or by the Executive for Good Reason, subject to the Executive releasing the Company
    (or its successor) from claims by executing and timely returning a form provided by the Company (or its successor), which form shall
    be irrevocable no later than sixty (60) days following the date of termination of the Executive&rsquo;s employment with the Company,
    the Executive shall receive: (a) any Accrued Obligations, payable in a lump sum within the time period required by applicable law,
    and in no event later than thirty (30) days following the date of termination of the Executive&rsquo;s employment with the Company;
    (b) severance pay equal to the Executive&rsquo;s Base Salary for the Severance Period plus the full amount of the Performance Bonus
    for the year in which the termination of the Executive&rsquo;s employment occurs, payable as a lump sum within the same time period
    as the Accrued Obligations; and (c) an additional lump sum payment equivalent to the Company&rsquo;s portion of the premium payable
    under the Company&rsquo;s health insurance benefits and sufficient to cover twelve (12) months of COBRA coverage for the Executive,
    such amount be paid on the Company&rsquo;s first regular pay date no later than on the sixtieth (60th) day following the date of
    termination of the Executive&rsquo;s employment. In addition, in the event of termination of the Executive&rsquo;s employment under
    this <U>Section 3</U> of <U>Article IV</U> following a Change in Control: (d) all unvested stock options and restricted stock units
    granted by the Company to the Executive prior to the Change in Control, that have been assumed or substituted by the Company&rsquo;s
    successor, shall become fully vested as of the date of termination of the Executive&rsquo;s employment; and (e) the time period in
    which the Executive may exercise his vested stock options shall be extended to the earlier of (i) the original expiration date of
    a certain option grant, or (ii) twelve (12) months following the date of termination of the Executive&rsquo;s employment.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Survival</U>.
    </B>Upon termination or expiration of the Term of this Agreement, the Executive&rsquo;s post-termination obligations shall continue
    as set forth in <U>Article V</U> below.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 119.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>RESTRICTIVE
COVENANTS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Restrictive
                                            Covenants</U>. </B>In consideration for (i) the Company&rsquo;s promise to provide Confidential
                                            Information to the Executive, (ii) the substantial economic investment made by the Company
                                            in the Confidential Information and goodwill of the Company, and/or the business opportunities
                                            disclosed or entrusted to the Executive, (iii) access to the Company&rsquo;s customers and
                                            clients, and (iv) the Company&rsquo;s employment of the Executive pursuant to this Agreement
                                            and the compensation and other benefits provided by the Company to the Executive, to protect
                                            the Company&rsquo;s Confidential Information and business goodwill of the Company, the Executive
                                            agrees to the following restrictive covenants. For the purposes of this <U>Article V</U>,
                                            the term <I>&ldquo;<B>Company</B>&rdquo; </I>shall be read as broadly as possible to include,
                                            without limitation, any of its affiliates.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 77.95pt; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>No
    Unauthorized Use or Disclosure of Confidential Information</U>. </B>The Executive acknowledges and agrees that Confidential Information
    is proprietary to and a trade secret of the Company and, as such, is a special and unique asset of the Company, and that any disclosure
    or unauthorized use of any Confidential Information by the Executive will cause irreparable harm and loss to the Company. The Executive
    understands and acknowledges that each and every component of the Confidential Information (i) has been developed by the Company
    at significant effort and expense and is sufficiently secret to derive economic value from not being generally known to other parties,
    and (ii) constitutes a protectable business interest of the Company. The Executive acknowledges and agrees that the Company owns
    the Confidential Information. The Executive agrees not to dispute, contest, or deny any such ownership rights either during or after
    the Executive&rsquo;s employment with the Company. The Executive agrees to preserve and protect the confidentiality of all Confidential
    Information. Throughout the Executive&rsquo;s employment with the Company and as reasonably necessary thereafter: (i) the Executive
    shall hold all Confidential Information in the strictest confidence, take all reasonable precautions to prevent its inadvertent disclosure
    to any unauthorized person, and follow all Company policies to protect the Confidential Information; and (ii) the Executive shall
    not, directly or indirectly, utilize, disclose or make available to any other person or entity, any of the Confidential Information,
    other than in the proper performance of the Executive&rsquo;s duties.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Return
    of Property and Confidential Information</U>. </B>Upon termination of the Executive&rsquo;s employment for any reason, the Executive
    shall immediately return and deliver to the Company any and all Confidential Information, software, devices, cell phones, personal
    data assistants, credit cards, data, reports, proposals, lists, correspondence, materials, equipment, computers, hard drives, papers,
    books, records, documents, memoranda, manuals, e-mail, electronic or magnetic recordings or data, including all copies thereof, which
    belong to the Company or relate to the Company&rsquo;s business and which are in the Executive&rsquo;s possession, custody or control,
    whether prepared by the Executive or others. If at any time after termination of the Executive&rsquo;s employment the Executive determines
    that the Executive has any Confidential Information in the Executive&rsquo;s possession or control, the Executive shall immediately
    return to the Company all such Confidential Information in the Executive&rsquo;s possession or control, including all copies and
    portions thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Non-Competition</U>.
    </B>The Executive agrees that during the Restricted Period, other than in connection with the Executive&rsquo;s duties under this
    Agreement (including, without limitation, services to subsidiaries or affiliates of the Company), the Executive shall not, directly
    or indirectly, individually or as a principal, partner, stockholder, manager, agent, consultant, contractor, distributor, employee,
    lender, investor, or as a director or officer of any corporation or association, or in any other manner or capacity whatsoever, become
    employed by, control, manage, carry on, join, lend money for, operate, engage in, establish, perform services for, invest in, solicit
    investors for, consult for, do business with or otherwise engage in any business directly competing with the business of the Company.
    Notwithstanding the restrictions contained in this <U>Section A-3</U> of <U>Article V</U>, the Executive may own an aggregate of
    not more than two percent (2%) of the outstanding stock of any class of any corporation engaged in a busines that directly competes
    with the business of the Company if such stock is listed on a national securities exchange in the United States (or a comparable
    exchange in a foreign jurisdiction) or regularly traded in the over-the-counter market by a member of a national securities exchange.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Non-Solicitation</U>.
    </B>The Executive agrees that during the Restricted Period, other than in connection with Executive&rsquo;s duties under this Agreement,
    the Executive shall not use any Confidential Information to, directly or indirectly, either as a principal, manager, agent, employee,
    consultant, officer, director, stockholder, partner, investor or lender or in any other capacity, and whether personally or through
    other persons:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>a.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solicit
    business from, interfere with, induce, attempt to solicit business from, interfere with, induce or do business with any actual or
    prospective customer, client, supplier (including any content providers), manufacturer, vendor or licensor of the Company with whom
    the Company does or has done business;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>b.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attempt
    to influence, encourage, persuade or induce any actual or prospective customer, client, supplier (including any content providers),
    manufacturer, vendor or licensor of the Company with whom the Company does or did business to reduce the extent of its business dealings
    with the Company; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>c.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solicit,
    induce or attempt to solicit or induce, engage or hire, on behalf of the Executive or any other person or entity, any person who
    is an employee or consultant of the Company or who was employed by the Company within the in the United States within the preceding
    twelve (12) months.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 77.95pt; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Non-Disparagement</U>.
    </B>The Executive recognizes that the Company&rsquo;s goodwill and reputation are assets of great value to the Company which were
    obtained through great costs, time and effort. Therefore, the Executive agrees that during his employment and after the termination
    of his employment, the Executive shall not in any way, directly or indirectly, disparage, libel or defame the Company, its beneficial
    owners or its affiliates, their respective business or business practices, products or services, or employees or agents.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Tolling</U>.
    </B>If the Executive violates any of the restrictions contained in this <U>Article V</U>, the Restricted Period shall be suspended
    so as to not run in favor of the Executive from the time of the commencement of any violation until the time when the Executive cures
    the violation to the satisfaction of the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Remedies</U>.
    </B>The Executive acknowledges that, in view of the nature of the Company&rsquo;s business sand the Executive&rsquo;s position with
    the Company, the restrictions contained in this <U>Article V</U> are reasonable and necessary to protect the Company&rsquo;s legitimate
    business interests and that any violation thereof would result in irreparable injury to the Company. In the event of a breach by
    the Executive of <U>Article V</U> of this Agreement, the Company shall be entitled to a temporary restraining order and/or injunctive
    relief as appropriate to prevent the Execute from further breach. Such remedies shall not be deemed the exclusive remedies for a
    breach or threatened breach of this <U>Article V</U> but shall be in addition to any remedies available at law or in equity, including
    the recovery of damages from the Executive, the Executive&rsquo;s agents, any future employer of the Executive, and any person that
    conspires or aids and abets the Executive in such breach or threatened breach of this Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Reasonableness</U>.
    </B>The Executive hereby represents to the Company that the Executive has read and understands, and agrees to be bound by, the terms
    of this <U>Article V</U>. The Executive acknowledges that the geographic scope and duration of the covenants contained in this <U>Article
    V</U> are fair and reasonable in light of (i) the nature and wide geographic scope of the operations of the Company&rsquo;s business;
    (ii) the Executive&rsquo;s level of control over and contact with the business in the Restricted Area; and (iii) the amount of compensation,
    trade secrets and Confidential Information that the Executive is receiving in connection with the Executive&rsquo;s employment by
    the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Reformation</U>.
    </B>If any of the aforesaid restrictions are found by a court of competent jurisdiction to be unreasonable, or overly broad as to
    geographic area or time, or otherwise unenforceable, the Parties intend for the restrictions herein set forth to be modified by the
    court making such determination so as to be reasonable and enforceable and, as so modified, to be fully enforced. By agreeing to
    this contractual modification prospectively at this time, the Company and the Executive intend to make this provision enforceable
    under the law or laws of all applicable jurisdictions so that the entire agreement not to compete and this Agreement as prospectively
    modified shall remain in full force and effect and shall not be rendered void or illegal.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>No
    Previous Restrictive Agreements</U>. </B>The Executive represents that, except as disclosed to the Company, the Executive is not
    bound by the terms of any agreement with any previous employer or other party to refrain from using or disclosing any trade secret
    or confidential or proprietary information in the course of the Executive&rsquo;s employment with the Company or to refrain from
    competing, directly or indirectly, with the business of such previous employer or any other party. The Executive further represents
    that the Executive&rsquo;s performance of all the terms of this Agreement and the Executive&rsquo;s work duties for the Company do
    not and will not breach any agreement to keep in confidence proprietary information, knowledge or data acquired by the Executive
    in confidence or in trust prior to the Executive&rsquo;s employment with the Company. The Executive shall not disclose to the Company
    or induce the Company to use any confidential or proprietary information or material belonging to any previous employer or others.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>INTELLECTUAL
PROPERTY</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Assignment
    of Work Product</U>. </B>During the Executive&rsquo;s employment with the Company and for a period of twelve (12) months following
    termination of the Executive&rsquo;s employment for any reason, the Executive agrees that the Executive shall promptly make full
    written disclosure to the Company of all Work Product conceived, created, developed, made, reduced to practice, or fixed in a tangible
    medium of expression during the period of the Executive&rsquo;s employment with the Company. Executive hereby assigns and shall be
    deemed to have assigned to the Company or its designee, all of the Executive&rsquo;s right, title, and interest in and to any and
    all Work Product conceived, created, developed, made, reduced to practice, or fixed in a tangible medium of expression during the
    period of the Executive&rsquo;s employment the Company that: (a) relates in any manner to the previous, existing or contemplated
    business, work, or investigations of the Company; (b) is or was suggested by, has resulted or will result from, or has arisen or
    will arise out of any work that the Executive has done or may do for or on behalf of the Company; (c) has resulted or will result
    from or has arisen or will arise out of any materials or information that may have been disclosed or otherwise made available to
    the Executive as a result of duties assigned to the Executive by the Company; or (d) has been or will be otherwise made through the
    use of the Company&rsquo;s time, information, facilities, or materials, even if conceived, created, developed, made, reduced to practice,
    or fixed during other than working hours. The Executive further acknowledges that all original works of authorship that have been
    or will be made or fixed in a tangible medium of expression by the Executive (solely or jointly with others) within the scope of
    the Executive&rsquo;s employment with the Company that are protectable by copyright are &ldquo;Works Made for Hire,&rdquo; as that
    term is defined in the United States Copyright Act. The Executive understands and agrees that the decision whether or not to commercialize
    or market any Work Product is within the Company&rsquo;s sole discretion and for the Company&rsquo;s sole benefit, and that no royalty
    will be due to the Executive as a result of the Company&rsquo;s efforts to commercialize or market any such Work Product.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Patent
    and Copyright Registrations</U>. </B>The Executive agrees to reasonably assist, at the Company&rsquo;s expense, the Company or its
    designee(s) in securing the Company&rsquo;s rights in any Work Product in any country, including (without limitation) by protecting
    the Company&rsquo;s Confidential Information and data, executing any applications, specifications, oaths, assignments, affidavits,
    and all other instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign
    and convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such
    Work Product. The Executive further agrees that, insofar it is within the Executive&rsquo;s power to do so, the Executive&rsquo;s
    obligation to execute or cause to be executed any such instrument or papers after the termination of this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>MISCELLANEOUS
PROVISIONS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Governing
    Law</U>. </B>This Agreement shall be governed by and construed under the laws of the State of New York. Venue of any litigation arising
    from this Agreement or any disputes relating to the Executive&rsquo;s employment shall be in the United States District Court for
    the Southern District of New York, or a state district court of competent jurisdiction in New York, New York. The Executive and the
    Company hereby consent to, and agree not to challenge, personal or subject matter jurisdiction in the United States District Court
    for the Southern District of New York, or a state district court of competent jurisdiction in New York, New York, for any dispute
    relating to or arising out of this Agreement or the Executive&rsquo;s employment with the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Headings</U>.
    </B>The paragraph headings contained in this Agreement are for convenience only and shall in no way or manner be construed as a part
    of this Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Severability</U>.
    </B>In the event that any court of competent jurisdiction holds any provision in this Agreement to be invalid, illegal or unenforceable
    in any respect, the remaining provisions shall not be affected or invalidated and shall remain in full force and effect.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Entire
    Agreement</U>. </B>This Agreement constitutes the entire agreement between the Parties, and fully supersedes any and all prior agreements,
    understanding or representations between the Parties pertaining to or concerning the subject matter of this Agreement, including,
    without limitation, the Executive&rsquo;s employment with the Company. No oral statements or prior written material not specifically
    incorporated in this Agreement shall be of any force and effect, and no changes in or additions to this Agreement shall be recognized,
    unless incorporated in this Agreement by written amendment, such amendment to become effective on the date stipulated in it. Any
    amendment to this Agreement must be signed by all parties to this Agreement. The Executive acknowledges and represents that in executing
    this Agreement, the Executive did not rely, and has not relied, on any communications, promises, statements, inducements, or representation(s),
    oral or written, by the Company, except as expressly contained in this Agreement. The Parties represent that they relied on their
    own judgment in entering into this Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Waiver</U>.
    </B>No waiver of any breach of this Agreement shall be construed to be a waiver as to succeeding breaches. The failure of a Party
    to insist in any one or more instances upon the other Party&rsquo;s performance of any terms or conditions of this Agreement shall
    not be construed as a waiver of future performance of any such term, covenant or condition, but the obligations of either Party with
    respect thereto shall continue in full force and effect. The breach by one Party to this Agreement shall not preclude equitable relief
    or performance of the obligations in <U>Article V</U>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Modification</U>.
    </B>The provisions of this Agreement may be amended, modified or waived only with the prior written consent of the Company and the
    Executive, and no course of conduct or failure or delay in enforcing the provisions of this Agreement shall be construed as a waiver
    of such provisions or affect the validity, binding effect or enforceability of this Agreement or any provision hereof.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>G.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Beneficiaries
    and Assignment</U>. </B>This Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective
    heirs, successors, estates and/or legal representatives. The Executive may not assign this Agreement to a third party without the
    prior written approval of the Company. If the Company undergoes a Change in Control, The Company may assign its rights, together
    with its obligations hereunder, to any affiliate, subsidiary, or successor of the Company. Notwithstanding any such assignment by
    the Company, the Executive shall be entitled to receive compensation as set forth in <U>Section B.2.</U> of <U>Article IV</U> hereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK. SIGNATURE PAGE FOLLOWS.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company and the Executive have caused this Agreement to be executed on the date first set forth above, to be effective
as of that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE:</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>/s/ </I></B><I>Brian Murphy</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Murphy</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPANY:</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NanoVibronix,
    Inc.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stephen Brown</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Brown</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.62
<SEQUENCE>3
<FILENAME>ex10-62.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
10.62</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EMPLOYMENT
AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
EMPLOYMENT AGREEMENT </B>(this &ldquo;<B><I>Agreement</I></B>&rdquo;) is dated as of January 1, 2022 (the <I>&ldquo;<B>Effective Date</B>&rdquo;</I>)
and is entered into by and between Stephen Brown (the &ldquo;<B><I>Executive</I></B>&rdquo;) and NanoVibronix, Inc. (the &ldquo;<B><I>Company</I></B>&rdquo;).
The Company and the Executive shall be referred to herein as the &ldquo;<B><I>Parties</I></B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Executive is presently serving as the Chief Financial Officer (CFO) of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company and the Executive mutually desire to memorialize the terms and conditions under which the Executive will continue to serve
as the CFO of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company hereby employs the Executive, and the Executive hereby accepts employment as the CFO of the Company for the period and subject
to the term and conditions set forth in this Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company and the Executive are parties to a certain Stock Options Purchase Agreement that, among other things, affects the Parties&rsquo;
existing and continued employment relationship and contains certain conditions and limitations on the Executive&rsquo;s right to purchase
a portion of the Company&rsquo;s capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the mutual promises and agreements contained herein, and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the Parties hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>DEFINITIONS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Term</B>&rdquo;
    </I>refers to the period during which the Executive is employed by the Company as the Company&rsquo;s CFO under this Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Confidential
    Information</B>&rdquo; </I>includes any trade secrets or confidential or proprietary information of the Company, including, but not
    limited to, the following: methods of operation, products, inventions, services, processes, equipment, know-how, technology, technical
    data, policies, strategies, designs, formulas, developmental or experimental work, improvements, discoveries, research, plans for
    research or future products and services, database schemas or tables, software, development tools or techniques, training procedures,
    training techniques, training manuals, business information, marketing and sales methods, plans and strategies, competitors, markets,
    market surveys, techniques, production processes, infrastructure, business plans, distribution and installation plans, processes
    and strategies, methodologies, budgets, financial data and information, customer and client information, prices and costs, fees,
    customer and client lists and profiles, employee, customer and client nonpublic personal information, supplier lists, business records,
    product construction, product specifications, audit processes, pricing strategies, business strategies, marketing and promotional
    practices, management methods and information, plans, reports, recommendations and conclusions, information regarding the skills
    and compensation of employees and contractors of the Company, and other business information disclosed to the Executive by the Company,
    either directly or indirectly, in writing, orally, or by drawings or observation. <I>&ldquo;<B>Confidential Information</B>&rdquo;
    </I>does not include, and there shall be no obligation hereunder with respect to, information that (i) is generally available to
    the public on the date of this Agreement or (ii) becomes generally available to the public other than as a result of a disclosure
    not otherwise permissible hereunder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Cause</B>,&rdquo;
    </I>as used herein in reference to termination of the Executive&rsquo;s employment with the Company, shall mean the Executive&rsquo;s
    (a) intentional and material dishonesty in the performance of the Executive&rsquo;s duties for the Company, including any acts of
    theft, embezzlement, or fraud; (b) indictment or conviction of, or pleading nolo contendere or guilty to, a felony or a crime involving
    moral turpitude; (c) refusal to perform, or intentional disregard of, in any material respect, the Executive&rsquo;s duties and responsibilities
    under this Agreement; and (d) incurable material breach of this Agreement or any other agreement to which the Executive and the Company
    are parties. In each such event listed above, if the circumstances are curable, the Company shall give the Executive written notice
    thereof which shall specify in reasonable detail the circumstances constituting Cause, and there shall be no Cause with respect to
    any such circumstances if cured by the Executive within thirty (30) days after such notice.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Good Reason</B>,&rdquo;
    </I>as used herein in reference to termination of the Executive&rsquo;s employment with the Company, shall mean: (a) any material
    reduction, without the Executive&rsquo;s consent, in the Executive&rsquo;s duties or responsibilities; (b) a material breach by the
    Company of this Agreement or any other agreement to which the Executive and the Company are parties; (c) any material reduction in
    the Executive&rsquo;s then current base salary plus target bonus opportunity compensation; or (d) any requirement that the Executive
    relocate or spend more than 50% of the next fiscal year in a location more than 50 miles from his current place of residence. In
    each such event listed above, the Executive shall give the Company written notice thereof which shall specify in reasonable detail
    the circumstances constituting Good Reason, and there shall be no Good Reason with respect to any such circumstances if cured by
    the Company within thirty (30) days after such notice.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Change in
    Control</B>&rdquo; </I>shall mean: (a) any merger, acquisition or similar transaction or series of related transactions in which
    the Company is not the surviving entity, except for a transaction the principal purpose of which is to change the jurisdiction in
    which the Company is incorporated; (b) the sale, transfer or other disposition of all or substantially all of the assets of the Company;
    or (c) any reverse merger or acquisition in which the Company is the surviving entity but in which more than fifty percent (50%)
    of the Company&rsquo;s outstanding voting stock is transferred to holders different from those who held the stock immediately prior
    to such merger.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Restricted
    Period</B>&rdquo; </I>means during the Executive&rsquo;s employment with the Company and for a period of twelve (12) months immediately
    following the date of termination of Executive&rsquo;s employment with the Company for any reason.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>G.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<B>Competing
    Business</B>&rdquo; </I>means any business, individual, partnership, firm, corporation or other entity that is competing with any
    aspect of the Company&rsquo;s business.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>H.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Work Product</I></B>&rdquo;
    shall mean, collectively, all work product, information, inventions, original works of authorship, ideas, know-how, processes, designs,
    computer programs, photographs, illustrations, developments, trade secrets and discoveries, including improvements thereto, that
    the Executive conceives, creates, develops, makes, reduces to practice, or fixes in a tangible medium of expression, either alone
    or with others.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SERVICES
TO BE PROVIDED BY EXECUTIVE</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Position and Responsibilities</U>.
    </B>The Executive shall be employed and serve as CFO of the Company (together with such other position or positions consistent with
    the Executive&rsquo;s title as the Company&rsquo;s Board of Director&rsquo;s (the <I>&ldquo;<B>Board</B>&rdquo;</I>) shall specify
    from time to time) and shall report directly to the Board and the Chief Executive Officer. As the CFO, the Executive shall have such
    duties and responsibilities customarily commensurate with such title, and perform services for the Company as requested or as needed.
    Subject to the Executive performing his duties hereunder, the Company will use its best efforts to cause the Executive to be/remain
    elected as the Chief Financial Officer.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Performance</U>.
    </B>The Executive shall devote, for the number of hours and during the times mutually agreed to by the parties, the Executive&rsquo;s
    time, energy, skill and reasonable best efforts to the performance of the Executive&rsquo;s duties hereunder in a manner that will
    faithfully and diligently further the business and interests of the Company, and shall exercise reasonable best efforts to perform
    the Executive&rsquo;s duties in a diligent, trustworthy, good faith and business-like manner, all for the purpose of advancing the
    business of the Company. The Executive shall at all times act in a manner consistent with Executive&rsquo;s position as CFO.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Compliance</U>. </B>In
    the performance of the Executive&rsquo;s duties hereunder and as the CFO of the Company, the Executive agrees to at all times act
    in accordance with high business and ethical standards and in accordance with the general fiduciary duty of executive officers and
    directors of the Company. The Executive shall comply with policies, codes of conduct, codes of ethics, written manuals and lawful
    directives of the Company and any of its affiliates. The Executive shall keep the Board promptly and fully informed of the Executive&rsquo;s
    conduct in connection with the business and financial affairs of the Company. The Executive shall report to the Board the Executive&rsquo;s
    own wrongdoing and any wrongdoing or proposed wrongdoing of any other employee, director, affiliate or contractor of the Company
    or other person performing services on behalf of or for the Company immediately upon becoming aware of it.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>COMPENSATION
FOR SERVICES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
compensation for all services the Executive will perform under this Agreement, the Company shall pay the Executive, and the Executive
shall accept as full compensation, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Base Salary</U>.
    </B>The Company shall pay the Executive an annual salary of <B><U>$250,000 (USD)</U></B>, less any applicable payroll deductions
    and tax withholdings (the &ldquo;<B><I>Base Salary</I></B>&rdquo;), for all services rendered by the Executive under this Agreement.
    The Company shall pay the Executive the Base Salary in accordance with standard payroll practices of the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Performance Bonus</U>.
    </B>During each year of the Term, the Executive shall be eligible to receive an annual bonus (<I>&ldquo;<B>Performance Bonus</B>&rdquo;</I>)
    of up to <B><U>$50,000 (USD)</U></B>, less applicable payroll deductions and tax withholdings. The Performance Bonus shall be based
    on the extent to which the Executive has met performance criteria for the year, as determined in good faith by the Board or the Compensation
    Committee of the Board, and be paid within thirty (30) days of the Company&rsquo;s issuance of its audited financial statements for
    that year on Form 10-K (in the calendar year following the calendar year to which the Performance Bonus relates).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Stock Options</U>.
    </B>The Executive has received, and may be eligible to receive, certain grants of incentive stock options to purchase shares of common
    stock of the Company (the &ldquo;<B>Stock Options</B>&rdquo;) as set forth separately in the certain Stock Options Purchase Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Expenses</U>. </B>The
    Company agrees that, during the Executive&rsquo;s employment, it will reimburse the Executive for out-of-pocket expenses reasonably
    incurred in connection with the Executive&rsquo;s performance of the Executive&rsquo;s services hereunder, upon the presentation
    by the Executive of an itemized accounting of such expenditures, with supporting receipts. Reimbursements shall be in compliance
    with the Company&rsquo;s expense reimbursement policies.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Vacation</U>. </B>The
    Executive shall be eligible for four (4) weeks paid vacation in accordance with the Company&rsquo;s policy in effect from time to
    time.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Other Benefits</U>.
    </B>The Executive is entitled to participate in any group health insurance plan, 401(k) plan, disability plan, group life plan, and
    any other benefit or welfare program or policy that is made generally available, from time to time, to other employees of the Company,
    on a basis consistent with such participation and subject to the terms of the plan documents, as such plans may be modified, amended,
    terminated, or replaced from time to time. Notwithstanding anything to the contrary contained herein, in the event that the Company
    does not have a group health plan on the Effective Date and the Executive (and his eligible dependents) elect to continue group health
    plan coverage under the Executive&rsquo;s prior employer&rsquo;s group health plan in accordance with the Consolidated Omnibus Budget
    Reconciliation Act of 1985, as amended (&ldquo;COBRA&rdquo;), the Company agrees to pay or reimburse the Executive for 100% of the
    premiums due with respect to such COBRA coverage upon presentation by the Executive to the Company of a statement of premiums due
    with respect to such coverage, from the Effective Date until the earliest of: (i) the date the Executive and his eligible dependents
    are eligible for coverage under a group health plan of the Company; (ii) the end of the Term; or (iii) the date the Executive&rsquo;s
    COBRA coverage terminates for any reason (other than non-payment of premiums).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>G.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Code Section 409A</U>.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent (a) any payments
    to which the Executive becomes entitled under this Agreement, or any agreement or plan referenced herein, in connection with the
    termination of Executive&rsquo;s employment with the Company or the Executive&rsquo;s separation from service to the Company constitute
    deferred compensation subject to Section 409A of the Internal Revenue Code of 1986 as amended (the &ldquo;Code&rdquo;); (b) the Executive
    is deemed at the time of his termination/separation to be a &ldquo;specified employee&rdquo; under Section 409A of the Code; and
    (c) at the time of the Executive&rsquo;s termination, the Company is publicly traded (as defined in Section 409A of the Code), then
    such payments (other than any payments permitted by Section 409A of the Code to be paid within six (6) months of the Executive&rsquo;s
    termination/separation) shall not be made until the earlier of (1) the first day of the seventh month following the Executive&rsquo;s
    termination/separation, or (2) the date of the Executive&rsquo;s death following such termination/separation. Upon the expiration
    of the applicable deferral period, any payments which would have otherwise been made during that period (whether in a single lump
    sum or in installments) in the absence of this Article III shall be paid to the Executive or the Executive&rsquo;s beneficiary in
    one lump sum, plus interest thereon, at the Delayed Payment Interest Rate (as defined below) computed from the date on which each
    such delayed payment otherwise would have been made to the Executive until the date of payment. For purposes of the foregoing, the
    <I>&ldquo;<B>Delayed Payment Interest Rate</B>&rdquo; </I>shall mean the national average annual rate of interest payable on jumbo
    six-month bank certificates of deposit, as quoted in the business section of the most recently published Sunday edition of The New
    York Times preceding the date of termination of the Executive&rsquo;s employment with the Company or the Executive&rsquo;s separation
    from service to the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent any benefits
    provided under <U>Article III</U> above are otherwise taxable to the Executive, such benefits shall, for purposes of Section 409A
    of the Code, be provided as separate in-kind payments of those benefits, and the provision of in-kind benefits during one calendar
    year shall not affect the in-kind benefits to be provided in any other calendar year.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the case of any amounts
    payable to the Executive under this Agreement, or under any plan of the Company, that may be treated as payable in the form of &ldquo;a
    series of installment payments,&rdquo; as defined in Treas. Reg. &sect;l.409A-2(b)(2)(iii), the Executive&rsquo;s right to receive
    such payments shall be treated as a right to receive a series of separate payments for purposes of Treas. Reg. &sect;l.409A-2(b)(2)(iii).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It is intended that this
    Agreement comply with or be exempt from the provisions of Section 409A of the Code and the Treasury Regulations and guidance of general
    applicability issued thereunder, and in furtherance of this intent, this Agreement shall be interpreted, operated, and administered
    in a manner consistent with such intent.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>TERM
&amp; TERMINATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Term of Employment</U>.
    </B>The Term of the Executive&rsquo;s employment under this Agreement shall continue in effect until the second anniversary of the
    Effective Date, unless earlier terminated by either party in accordance with this <U>Article IV</U>. On the second anniversary of
    the Effective Date, the Term will automatically renew on an annual basis unless written notification is provided by either Party
    of the desire not to renew/extend the Term for the subsequent year.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination</U>.
    </B>Either Party may terminate the Executive&rsquo;s employment with the Company at any time upon 90 days written notice to the other
    Party, with the date of termination of the Executive&rsquo;s employment with the Company being the date provided in the notice of
    termination. Upon termination of the Executive&rsquo;s employment, the Company shall pay the Executive: (i) any earned but unpaid
    Performance Bonus for the calendar year prior to the calendar year in which the Executive&rsquo;s termination occurs, with payment
    of such Performance Bonus being due within the earlier of the time period specified in <U>Article III, Section B</U> or as specified
    in this <U>Article IV, Section B</U>; (ii) any accrued and unpaid vacation or similar pay to which the Executive is entitled as a
    matter of law or Company policy; and (iii) any unreimbursed expenses properly incurred prior to the date of termination (the &ldquo;<B><I>Accrued
    Obligations</I></B>&rdquo;). The Accrued Obligations shall be payable in a lump sum within the time period required by applicable
    law, and in no event later than thirty (30) days following the date of termination of the Executive&rsquo;s employment. Except for
    the Accrued Obligations and any other payments owed pursuant to the applicable scenarios in <U>Sections 1-3</U> below, upon termination
    of the Executive&rsquo;s employment, the Company shall have no further liability or obligations to the Executive in connection with
    the Executive&rsquo;s employment under this Agreement. The Executive&rsquo;s termination of employment under this Agreement shall
    also constitute the Executive&rsquo;s resignation as an officer or director of any affiliate or subsidiary of the Company, as applicable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination for Cause
    or Resignation Without Good Reason</U>. </B>In the event the Company terminates the Executive&rsquo;s employment for Cause or the
    Executive voluntarily resigns without Good Reason, the Company shall have no further liability or obligation to the Executive under
    this Agreement or in connection with the Executive&rsquo;s employment hereunder, except for the Accrued Obligations. The Accrued
    Obligations shall be payable in a lump sum within the me period required by applicable law, and in no event later than thirty (30)
    days following the date of termination of the Executive&rsquo;s employment with the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination Without
    Cause or Resignation For Good Reason</U>. </B>In the event the Executive&rsquo;s employment is terminated by the Company without
    Cause or by the Executive for Good Reason, and subject to the Executive releasing the Company from claims by executing and timely
    returning a form provided by the Company, which form shall be irrevocable no later than sixty (60) days following the date of the
    Executive&rsquo;s termination of employment, the Executive shall receive the following: (a) any Accrued Obligations, payable in a
    lump sum within the time period required by applicable law, and in no event later than thirty (30) days following the date of termination
    of the Executive&rsquo;s employment with the Company; (b) severance pay in an amount equal to the Executive&rsquo;s Base Salary for
    twelve (12) months (the <I>&ldquo;<B>Severance Period</B>&rdquo;</I>) plus the full amount of the Performance Bonus for the year
    in which the termination of the Executive occurs, payable either as a lump sum within the same time period as the Accrued Obligations
    or in equal installments in accordance with the Company&rsquo;s standard payroll policies, with the first installment being paid
    no later than sixty (60) days following the Company&rsquo;s first regular payment date following the date of termination of the Executive&rsquo;s
    employment with the Company, in which event such first payment shall include all installments that would otherwise already have been
    paid to the Executive during the period of up to sixty (60) days following the date of termination of the Executive&rsquo;s employment
    with the Company had payments of the installments commenced immediately following the date of termination of the Executive&rsquo;s
    employment with the Company; (c) an additional lump sum payment equivalent to the Company&rsquo;s portion of the premium payable
    under the Company&rsquo;s health insurance benefits and sufficient to cover twelve (12) months of COBRA coverage for the Executive,
    such amount be paid on the Company&rsquo;s first regular pay date no later than on the sixtieth (60th) day following the date of
    the Executive&rsquo;s termination.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination Following
    a Change In Control</U>.</B> In the event that, following a Change in Control, the Executive&rsquo;s employment is terminated by
    the Company (or its successor) without Cause or by the Executive for Good Reason, subject to the Executive releasing the Company
    (or its successor) from claims by executing and timely returning a form provided by the Company (or its successor), which form shall
    be irrevocable no later than sixty (60) days following the date of termination of the Executive&rsquo;s employment with the Company,
    the Executive shall receive: (a) any Accrued Obligations, payable in a lump sum within the time period required by applicable law,
    and in no event later than thirty (30) days following the date of termination of the Executive&rsquo;s employment with the Company;
    (b) severance pay equal to the Executive&rsquo;s Base Salary for the Severance Period plus the full amount of the Performance Bonus
    for the year in which the termination of the Executive&rsquo;s employment occurs, payable as a lump sum within the same time period
    as the Accrued Obligations; and (c) an additional lump sum payment equivalent to the Company&rsquo;s portion of the premium payable
    under the Company&rsquo;s health insurance benefits and sufficient to cover twelve (12) months of COBRA coverage for the Executive,
    such amount be paid on the Company&rsquo;s first regular pay date no later than on the sixtieth (60th) day following the date of
    termination of the Executive&rsquo;s employment. In addition, in the event of termination of the Executive&rsquo;s employment under
    this <U>Section 3</U> of <U>Article IV</U> following a Change in Control: (d) all unvested stock options and restricted stock units
    granted by the Company to the Executive prior to the Change in Control, that have been assumed or substituted by the Company&rsquo;s
    successor, shall become fully vested as of the date of termination of the Executive&rsquo;s employment; and (e) the time period in
    which the Executive may exercise his vested stock options shall be extended to the earlier of (i) the original expiration date of
    a certain option grant, or (ii) twelve (12) months following the date of termination of the Executive&rsquo;s employment.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Survival</U>. </B>Upon
    termination or expiration of the Term of this Agreement, the Executive&rsquo;s post-termination obligations shall continue as set
    forth in <U>Article V</U> below.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>RESTRICTIVE
COVENANTS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Restrictive Covenants</U>.
    </B>In consideration for (i) the Company&rsquo;s promise to provide Confidential Information to the Executive, (ii) the substantial
    economic investment made by the Company in the Confidential Information and goodwill of the Company, and/or the business opportunities
    disclosed or entrusted to the Executive, (iii) access to the Company&rsquo;s customers and clients, and (iv) the Company&rsquo;s
    employment of the Executive pursuant to this Agreement and the compensation and other benefits provided by the Company to the Executive,
    to protect the Company&rsquo;s Confidential Information and business goodwill of the Company, the Executive agrees to the following
    restrictive covenants. For the purposes of this <U>Article V</U>, the term <I>&ldquo;<B>Company</B>&rdquo; </I>shall be read as broadly
    as possible to include, without limitation, any of its subsidiaries or affiliates.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 78.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>No Unauthorized Use
    or Disclosure of Confidential Information</U>. </B>The Executive acknowledges and agrees that Confidential Information is proprietary
    to and a trade secret of the Company and, as such, is a special and unique asset of the Company, and that any disclosure or unauthorized
    use of any Confidential Information by the Executive will cause irreparable harm and loss to the Company. The Executive understands
    and acknowledges that each and every component of the Confidential Information (i) has been developed by the Company at significant
    effort and expense and is sufficiently secret to derive economic value from not being generally known to other parties, and (ii)
    constitutes a protectable business interest of the Company. The Executive acknowledges and agrees that the Company owns the Confidential
    Information. The Executive agrees not to dispute, contest, or deny any such ownership rights either during or after the Executive&rsquo;s
    employment with the Company. The Executive agrees to preserve and protect the confidentiality of all Confidential Information. Throughout
    the Executive&rsquo;s employment with the Company and as reasonably necessary hereafter: (i) the Executive shall hold all Confidential
    Information in the strictest confidence, take all reasonable precautions to prevent its inadvertent disclosure to any unauthorized
    person, and follow all Company policies protecting the Confidential Information; and (ii) the Executive shall not, directly or indirectly,
    utilize, disclose or make available to any other person or entity, any of the Confidential Information, other than in the proper
    performance of the Executive&rsquo;s duties.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Return of Property
    and Confidential Information</U>. </B>Upon termination of the Executive&rsquo;s employment with the Company for any reason, the Executive
    shall immediately return and deliver to the Company any and all Confidential Information, software, devices, cell phones, personal
    data assistants, credit cards, data, reports, proposals, lists, correspondence, materials, equipment, computers, hard drives, papers,
    books, records, documents, memoranda, manuals, e-mail, electronic or magnetic recordings or data, including all copies thereof, which
    belong to the Company or relate to the Company&rsquo;s business and which are in the Executive&rsquo;s possession, custody or control,
    whether prepared by the Executive or others. If at any time after termination of the Executive&rsquo;s employment the Executive determines
    that the Executive has any Confidential Information in the Executive&rsquo;s possession or control, the Executive shall immediately
    return to the Company all such Confidential Information in the Executive&rsquo;s possession or control, including all copies and
    portions thereof.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Non-Competition</U>.
    </B>The Executive agrees that during the Restricted Period, other than in connection with the Executive&rsquo;s duties under this
    Agreement (including, without limitation, services to subsidiaries or affiliates of the Company), the Executive shall not, directly
    or indirectly, individually or as a principal, partner, stockholder, manager, agent, consultant, contractor, distributor, employee,
    lender, investor, or as a director or officer of any corporation or association, or in any other manner or capacity whatsoever, become
    employed by, control, manage, carry on, join, lend money for, operate, engage in, establish, perform services for, invest in, solicit
    investors for, consult for, do business with or otherwise engage in any business directly competing with the business of the Company.
    Notwithstanding the restrictions contained in this <U>Section A-3</U> of <U>Article V</U>, the Executive may own an aggregate of
    not more than two percent (2%) of the outstanding stock of any class of any corporation engaged in a business that directly competes
    with the business of the Company if such stock is listed on a national securities exchange in the United States (or a comparable
    exchange in a foreign jurisdiction) or regularly traded in the over-the-counter market by a member of a national securities exchange.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Non-Solicitation</U>.
    </B>The Executive agrees that during the Restricted Period, other than in connection with Executive&rsquo;s duties under this Agreement,
    the Executive shall not use any Confidential Information to, directly or indirectly, either as a principal, manager, agent, employee,
    consultant, officer, director, stockholder, partner, investor or lender or in any other capacity, and whether personally or through
    other persons:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>a.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solicit business from,
    interfere with, induce, attempt to solicit business from, interfere with, induce or do business with any actual or prospective customer,
    client, supplier (including any content providers), manufacturer, vendor or licensor of the Company with whom the Company does or
    has done business;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>b.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attempt to influence, encourage,
    persuade or induce any actual or prospective customer, client, supplier (including any content providers), manufacturer, vendor or
    licensor of the Company with whom the Company does or did business to reduce the extent of its business dealings with the Company;
    or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>c.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solicit, induce or attempt
    to solicit or induce, engage or hire, on behalf of the Executive or any other person or entity, any person who is an employee or
    consultant of the Company or who was employed by the Company within the in the United States within the preceding twelve (12) months.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 78.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Non-Disparagement</U>.
    </B>The Executive recognizes that the Company&rsquo;s goodwill and reputation are assets of great value to the Company which were
    obtained through great costs, time and effort. Therefore, the Executive agrees that during his employment and after the termination
    of his employment, the Executive shall not in any way, directly or indirectly, disparage, libel or defame the Company, its beneficial
    owners or its affiliates, their respective business or business practices, products or services, or employees or agents.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Tolling</U>. </B>If
    the Executive violates any of the restrictions contained in this <U>Article V</U>, the Restricted Period shall be suspended so as
    to not run in favor of the Executive from the time of the commencement of any violation until the time when the Executive cures the
    violation to the satisfaction of the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Remedies</U>. </B>The
    Executive acknowledges that, in view of the nature of the Company&rsquo;s business sand the Executive&rsquo;s position with the Company,
    the restrictions contained in this <U>Article V</U> are reasonable and necessary to protect the Company&rsquo;s legitimate business
    interests and that any violation thereof would result in irreparable injury to the Company. In the event of a breach by the Executive
    of <U>Article V</U> of this Agreement, the Company shall be entitled to a temporary restraining order and/or injunctive relief as
    appropriate to prevent the Execute from further breach. Such remedies shall not be deemed the exclusive remedies for a breach or
    threatened breach of this <U>Article V</U> but shall be in addition to any remedies available at law or in equity, including the
    recovery of damages from the Executive, the Executive&rsquo;s agents, any future employer of the Executive, and any person that conspires
    or aids and abets the Executive in such breach or threatened breach of this Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Reasonableness</U>.
    </B>The Executive hereby represents to the Company that the Executive has read and understands, and agrees to be bound by, the terms
    of this <U>Article V</U>. The Executive acknowledges that the covenants contained in this <U>Article V</U> are fair and reasonable
    in light of (i) the nature and wide geographic scope of the operations of the Company&rsquo;s business; (ii) the Executive&rsquo;s
    level of control over and contact with the business operations (regionally and/or internationally); and (iii) the amount of compensation,
    trade secrets and Confidential Information that the Executive is receiving in connection with the Executive&rsquo;s employment by
    the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Reformation</U>.
    </B>If any of the aforesaid restrictions are found by a court of competent jurisdiction to be unreasonable, or overly broad as to
    geographic area or time, or otherwise unenforceable, the Parties intend for the restrictions herein set forth to be modified by the
    court making such determination so as to be reasonable and enforceable and, as so modified, to be fully enforced. By agreeing to
    this contractual modification prospectively at this time, the Company and the Executive intend to make this provision enforceable
    under the law or laws of all applicable jurisdictions so that the entire agreement not to compete and this Agreement as prospectively
    modified shall remain in full force and effect and shall not be rendered void or illegal.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>No Previous Restrictive
    Agreements</U>. </B>The Executive represents that, except as disclosed to the Company, the Executive is not bound by the terms of
    any agreement with any previous employer or other party to refrain from using or disclosing any trade secret or confidential or proprietary
    information in the course of the Executive&rsquo;s employment with the Company or to refrain from competing, directly or indirectly,
    with the business of such previous employer or any other party. The Executive further represents that the Executive&rsquo;s performance
    of all the terms of this Agreement and the Executive&rsquo;s work duties for the Company do not and will not breach any agreement
    to keep in confidence any proprietary information, knowledge or data acquired by the Executive in confidence or in trust prior to
    the Executive&rsquo;s employment with the Company. The Executive shall not disclose to the Company or induce the Company to use any
    confidential or proprietary information or material belonging to any previous employer or other third parties.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>INTELLECTUAL
PROPERTY</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Assignment of Work
    Product</U>. </B>During the Executive&rsquo;s employment with the Company and the Restricted Period, the Executive agrees to promptly
    make full written disclosure to the Company of all Work Product of the Executive that was conceived, created, developed, made, reduced
    to practice, or fixed in a tangible medium of expression during the period of the Executive&rsquo;s employment with the Company.
    Executive hereby assigns and shall be deemed to have assigned to the Company or its designee(s), all of the Executive&rsquo;s right,
    title, and interest in and to any and all Work Product conceived, created, developed, made, reduced to practice, or fixed in a tangible
    medium of expression during the period of the Executive&rsquo;s employment the Company that: (a) relates in any manner to the previous,
    existing or contemplated business, work, or investigations of the Company; (b) is or was suggested by, has resulted or will result
    from, or has arisen or will arise out of any work that the Executive has done or may do for or on behalf of the Company; (c) has
    resulted or will result from or has arisen or will arise out of any materials or information that may have been disclosed or otherwise
    made available to the Executive as a result of duties assigned to the Executive by the Company; or (d) has been or will be otherwise
    made through the use of the Company&rsquo;s time, information, facilities, or materials, even if conceived, created, developed, made,
    reduced to practice, or fixed during other than working hours. The Executive further acknowledges that all original works of authorship
    that have been or will be made or fixed in a tangible medium of expression by the Executive (solely or jointly with others) within
    the scope of the Executive&rsquo;s employment with the Company that are protectable by copyright are &ldquo;Works Made for Hire,&rdquo;
    as that term is defined in the United States Copyright Act. The Executive understands and agrees that the decision whether or not
    to commercialize or market any Work Product shall be within the Company&rsquo;s sole discretion and for the Company&rsquo;s sole
    benefit, and that no royalty will be due to the Executive as a result of the Company&rsquo;s efforts to commercialize or market any
    such Work Product.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Patent and Copyright
    Registrations</U>. </B>The Executive agrees to reasonably assist, at the Company&rsquo;s expense, the Company or its designee(s)
    in securing the Company&rsquo;s rights in any Work Product in any country, including (without limitation) by protecting the Company&rsquo;s
    Confidential Information and data, executing any applications, specifications, oaths, assignments, affidavits, and all other instruments
    which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign and convey to the Company,
    its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Work Product. The Executive
    further agrees that, insofar it is within the Executive&rsquo;s power to do so, the Executive&rsquo;s obligation to execute or cause
    to be executed any such instrument or papers after the termination of this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>MISCELLANEOUS
PROVISIONS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Governing Law</U>.
    </B>This Agreement shall be governed by and construed under the laws of the State of New York. Venue of any litigation arising from
    this Agreement or any disputes relating to the Executive&rsquo;s employment shall be in the United States District Court for the
    Southern District of New York, or a state district court of competent jurisdiction in New York, New York. The Executive and the Company
    hereby consent to, and agree not to challenge, personal or subject matter jurisdiction in the United States District Court for the
    Southern District of New York, or a state district court of competent jurisdiction in New York, New York, for any dispute relating
    to or arising out of this Agreement or the Executive&rsquo;s employment with the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Headings</U>. </B>The
    paragraph headings contained in this Agreement are for convenience only and shall in no way or manner be construed as a part of this
    Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Severability</U>.
    </B>In the event that any court of competent jurisdiction holds any provision in this Agreement to be invalid, illegal or unenforceable
    in any respect, the remaining provisions shall not be affected or invalidated and shall remain in full force and effect.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Entire Agreement</U>.
    </B>This Agreement constitutes the entire agreement between the Parties, and fully supersedes any and all prior agreements, understanding
    or representations between the Parties pertaining to or concerning the subject matter of this Agreement, including, without limitation,
    the Executive&rsquo;s employment with the Company. No oral statements or prior written material not specifically incorporated in
    this Agreement shall be of any force and effect, and no changes in or additions to this Agreement shall be recognized, unless incorporated
    in this Agreement by written amendment, such amendment to become effective on the date stipulated in it. Any amendment to this Agreement
    must be signed by all parties to this Agreement. The Executive acknowledges and represents that in executing this Agreement, the
    Executive did not rely, and has not relied, on any communications, promises, statements, inducements, or representation(s), oral
    or written, by the Company, except as expressly contained in this Agreement. The Parties represent that they relied on their own
    judgment in entering into this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Waiver</U>. </B>No
    waiver of any breach of this Agreement shall be construed to be a waiver as to succeeding breaches. The failure of a Party to insist
    in any one or more instances upon the other Party&rsquo;s performance of any terms or conditions of this Agreement shall not be construed
    as a waiver of future performance of any such term, covenant or condition, but the obligations of either Party with respect thereto
    shall continue in full force and effect. The breach by one Party to this Agreement shall not preclude equitable relief or performance
    of the obligations in <U>Article V</U>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Modification</U>.
    </B>The provisions of this Agreement may be amended, modified or waived only with the prior written consent of the Company and the
    Executive, and no course of conduct or failure or delay in enforcing the provisions of this Agreement shall be construed as a waiver
    of such provisions or affect the validity, binding effect or enforceability of this Agreement or any provision hereof.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>G.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Beneficiaries and
    Assignment</U>. </B>This Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective heirs,
    successors, estates and/or legal representatives. The Executive may not assign this Agreement to a third party without prior written
    approval from the Company. If the Company undergoes a Change in Control, The Company may assign its rights, together with its obligations
    hereunder, to any affiliate, subsidiary, or successor of the Company. Notwithstanding any such assignment by the Company, the Executive
    shall be entitled to receive compensation as set forth in <U>Section B.2.</U> of <U>Article IV</U> hereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK. SIGNATURE PAGE FOLLOWS.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 35.95pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 11.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company and the Executive have caused this Agreement to be executed on the date first set forth above, to be effective
as of that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE:</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>/s/ </I></B><I>Stephen Brown</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen Brown</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPANY:</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NanoVibronix, Inc.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Brian
    Murphy</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Murphy</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>4
<FILENAME>ex31-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
31.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13a-14(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Brian Murphy, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this Amendment No. 1 on Form 10-K of NanoVibronix, Inc.; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
period covered by this report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 2, 2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brian Murphy</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Murphy</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.4
<SEQUENCE>5
<FILENAME>ex31-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
31.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Stephen Brown, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I have reviewed this Amendment
    No. 1 on Form 10-K of NanoVibronix, Inc.; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge,
    this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
    made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
    report.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 2, 2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stephen Brown</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen Brown</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial and
    Accounting Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>naov-20211231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa2HqbP9z5Z8uekhvWB+bRnKTyYnlehZQS+Cg07GITYE -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:NAOV="http://nanovibronix.com/20211231" elementFormDefault="qualified" targetNamespace="http://nanovibronix.com/20211231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://nanovibronix.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="naov-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="naov-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>naov-20211231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>naov-20211231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nanovibronix.com/role/Cover" xlink:href="naov-20211231.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nanovibronix.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140206688544584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Apr. 28, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K/A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">This
Amendment No. 1 to our Annual Report on Form 10-K (this &#8220;Amendment&#8221;) amends the Annual Report on Form 10-K for the fiscal
year ended December 31, 2021 of NanoVibronix, Inc., as originally filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
on April 15, 2022 (the &#8220;Form 10-K&#8221;). We are filing this Amendment to present the information required by Part III of Form
10-K that was previously omitted from the Form 10-K in reliance on General Instruction G(3) to Form 10-K because a definitive proxy statement
containing such information will not be filed within 120 days after the end of the fiscal year covered by the Form 10-K. Accordingly,
the reference on the cover page of the Form 10-K to the incorporation by reference of our definitive proxy statement into Part III of
the Form 10-K has been removed.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NanoVibronix, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001326706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">01-0801232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">525
    Executive Blvd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Elmsford<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(914)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">233-3004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NAOV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,447,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,997,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Marcum LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>form10-ka_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:NAOV="http://nanovibronix.com/20211231"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="naov-20211231.xsd" xlink:type="simple"/>
    <context id="From2021-01-01to2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326706</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326706</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-04-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326706</identifier>
        </entity>
        <period>
            <instant>2022-04-28</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Segment">
        <measure>NAOV:Segment</measure>
    </unit>
    <unit id="ILS">
        <measure>NAOV:Israelinewshekel</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-12-31">0001326706</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-01-01to2021-12-31">true</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2021-01-01to2021-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType contextRef="From2021-01-01to2021-12-31">10-K/A</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2021-01-01to2021-12-31">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2021-01-01to2021-12-31">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2021-01-01to2021-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2021-01-01to2021-12-31">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2021-01-01to2021-12-31">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2021-01-01to2021-12-31">001-36445</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2021-01-01to2021-12-31">NanoVibronix, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-01-01to2021-12-31">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-01-01to2021-12-31">01-0801232</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-01to2021-12-31">525     Executive Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-01to2021-12-31">Elmsford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-01-01to2021-12-31">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-01-01to2021-12-31">10523</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-01-01to2021-12-31">(914)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-01-01to2021-12-31">233-3004</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2021-01-01to2021-12-31">Common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-01-01to2021-12-31">NAOV</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-01-01to2021-12-31">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2021-01-01to2021-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2021-01-01to2021-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2021-01-01to2021-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2021-01-01to2021-12-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2021-01-01to2021-12-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2021-01-01to2021-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-01-01to2021-12-31">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2021-01-01to2021-12-31">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="From2021-01-01to2021-12-31">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">9447579000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2022-04-28" decimals="INF" unitRef="Shares">27997793</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorFirmId contextRef="From2021-01-01to2021-12-31">688</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2021-01-01to2021-12-31">Marcum LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2021-01-01to2021-12-31">New York, NY</dei:AuditorLocation>
    <dei:AmendmentDescription contextRef="From2021-01-01to2021-12-31">This
Amendment No. 1 to our Annual Report on Form 10-K (this &#x201c;Amendment&#x201d;) amends the Annual Report on Form 10-K for the fiscal
year ended December 31, 2021 of NanoVibronix, Inc., as originally filed with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;)
on April 15, 2022 (the &#x201c;Form 10-K&#x201d;). We are filing this Amendment to present the information required by Part III of Form
10-K that was previously omitted from the Form 10-K in reliance on General Instruction G(3) to Form 10-K because a definitive proxy statement
containing such information will not be filed within 120 days after the end of the fiscal year covered by the Form 10-K. Accordingly,
the reference on the cover page of the Form 10-K to the incorporation by reference of our definitive proxy statement into Part III of
the Form 10-K has been removed.</dei:AmendmentDescription>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;%U*+"K65J3- ]YB*G<^DLX+0K^ UR2':8I=C3I>'\ GO \^%\W,_)"#:'
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " "&,J)4!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( (8RHE1_VT_W[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( (8RHE297)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
MAC*B5&;X6^&D!P  M1T  !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( (8RHE2R]\)O[@(  (D.   -
M          "  ></  !X;"]S='EL97,N>&UL4$L! A0#%     @ AC*B5)>*
MNQS     $P(   L              ( ! !,  %]R96QS+RYR96QS4$L! A0#
M%     @ AC*B5*K$(A8S 0  (@(   \              ( !Z1,  'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( (8RHE0D'INBK0   /@!   :
M      "  4D5  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( (8RHE1ED'F2&0$  ,\#   3              "  2X6  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  '@7      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>37</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="form10-ka.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanovibronix.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K/A" original="form10-ka.htm">form10-ka.htm</File>
    <File>ex10-61.htm</File>
    <File>ex10-62.htm</File>
    <File>ex31-3.htm</File>
    <File>ex31-4.htm</File>
    <File>naov-20211231.xsd</File>
    <File>naov-20211231_lab.xml</File>
    <File>naov-20211231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form10-ka.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 3,
   "dts": {
    "inline": {
     "local": [
      "form10-ka.htm"
     ]
    },
    "labelLink": {
     "local": [
      "naov-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "naov-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "naov-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 63,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 37,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "NAOV",
   "nsuri": "http://nanovibronix.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-ka.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://nanovibronix.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-ka.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nanovibronix.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001493152-22-011691-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-011691-xbrl.zip
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MF?;PS@H%KX[YRDQ=L*_'\I#. LCR%AI=*?0'[#VX)5'>/P,C J95,N$A<RO
MGBW8O@6657XR:1KL#]K$6>GXH%T%]] *284MWF&2WDKO.U'$/M*\Y(!L4\5J
MJE6R,MK0LQ(#@\, $1Q[D]E/Y%RX*DQ%/#DOT$#'?_%12:&0!1.CR$?(;XB
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MO ZN#2;33N.KZ&PQA_?O%&ILXE?1H9IIGNK#'"?P67C3$WL7_N*WGMUVKY_
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M+SIOG<O3.R97J:W.@6M76")NE+C;M\:EFC476KJI]FP;9VUAS).F,JQKO2Z
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M_SE$-&\UHOG/(:(Y1#2_M27^58.%:]@_M"XN4,'T<3_,=>]1DXI01 7-'CR
MI0=+Z1<N\[RLMAK/[.0(N;HJ;OKIU'G24$.EZ*//MKVG:3C]TNH^E.3>SXK<
MD_W3LY.#O;.#CS#$O:./^X<[AV>G0T'N(%T><$'NB9B<:#SMY6 P8S/I5MG9
M0<:P(HFV..EDVVSV.SN*?$80B[GU):+M.3'8V0A;V!]DY!#J39(=^89%9(PJ
MND5B@T "/#D&,8,V'=GIA$'<,HB-]54L>2=!NN1Y0@6TG:*#+'DB?A&'XIM3
MUU>TQ(T6"S@Q99SF)9O-\(ZB)B.S=SA8743V\C+O4 PW@_E<L L@3HTT6:/B
MI(O>2>Y$2SM9!LT*F4:ZL06\:>#6XY>-YG7E4D]P9Y2BBM!Z5Q9NLCW*E>OA
MYGKIPC1'YSN--7)J;-J0W]&QW=$,/TW>MP8$=;-*C726D?-#-G-(A)9^T.DQ
M.N<5N3W&1:X2F\.D2*DJ;?-VR1P8N:A :F:&NY<QY#GBRY&77>IB"+2M\$4S
MR[H!_W5=RE#OL9?1%O'%+Q%H__S7]O/!6+HWXFQ=TC_7KU3F,(\^9*H&#E!0
M^_$/0:',6Q8M=4$NP65<L]';.&2,\:<LOTQU<JZE@M(W@%_.@AD#8@[,IE+%
MPK%SNI^;<"!,1:&K%EO&*UPWT!$^1G$I,&+N4S&O^3=9BF7G5@MT+$7H23!J
MA/'TDR/1$0\1NG04G;@J"9*8PJX8D$382V3#4P6<'=\.+VP+Y58%)0<"*"'.
M-F7$.0DGF8: 313H)PR-+4BRYED@EY?2C$K4%&4&NN(3N#O-YUV)"V_ ;& "
M[; I6WJ"1C>_5-K'4YBQ#")"Z<*N&XP2!H(C<FK4!?I-.4;,+4C0'>W[T.(0
M,]]OEAK&:J>6&*G=\:6AN/8B_VF6G4AW71::&Z ]TRMW;C@90%;9F52F)IC9
MSN/Y:0)? ML-FV*,R)L!M)&S'AZUH!U&$3!X#:S\U,P93;6T>9H6>1ME<K6L
M:^N5V6Q+R",=2I>ZD/Z@H4(5!\.E<K,)19.6;2U\0Y'7YSZK^\9!8UZ&4GI[
MPJHNHDRC)HO18*P^HQGP34[;H?8IN@?:-'96RBKL$ODJ*S?2&/%NU"?.LW1$
M4/P43K4KJ(:/%.<SE.*J$I2OE"_J>0HQLT4/7YG#&MLT=E8CA>  *, P"@ N
MA,^\Z)]T!RG0/R&P^T92#YTN.$_7?A(E&JY.@;J1LS#PJAG-@>T+;0<CYY(&
M(&:(J19.BUQ%YB@*^B')]#/.@9L5%[1?W@FH1H8P!*%>1O\:@E"W&H3ZUQ"$
M&H)0@UWUK>VJ]2NK.Z%D1A19QR3-+(0="N6K+:DO09#JZDS-AN@MQY7DSW 1
M25 WP5F81&>B4T,Y7'E+%1-U;(7*-P+),:DN58'Z@\8>73!CL<8*GBF8(Y@D
M1]J"5<(252DTS@PY6O': GN0@<E4)/ )?QX!:>C]Q'MA2O-2I?!G"G?@Y3E8
M527,FNAJ,TSZ,G0%YL3-.=(H#>@P1V^*544)FB&4L(?4B-XSSO-/);X,RY/P
MW7E<<V.%:*9G>8$52?@"!#7$QV_-0!N"?U-0GHH\ W.&]*3S3 ,+D,> LD:^
M,QX'>]XH.8NBF'/#0!*%SB>2R6K35],<U;SF_,-S"IT2T%J_%]?9.[A*G)F$
M+8=$N^H-M99P.2T;>8 3>DDL:5HVPXG;%\[)>O6&8:/1(.ERY79T,&E NHEY
M<L/]W*I&TGR_]7L[8\Q?,B7 GQ5F^35F(!QXK^(<G)6P-+1S2.!2,MYNC9C>
M7>.ZG4I>I]M'0R',O2!K*(2YBZORX MA#O-L"SD=B+@>:-!^?Q+RZZ"D],3G
M%W/N?ML3<#T0(C;] _ X)L.'&#<<W^R/=)7<0I3<-\M#72V/8;M14I]3):B
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MBZ4N5#F3$>@"\")%!@P,:M2L@ZPSC1(RUOP\I/98$4(?B65",RNZ'@94QM!
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MC"YI@$N;I>#$E ?X51GN@:A #02'GI QCC/^ 1'"@'#QA4VEX.Q[&5SN5QI
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MII9R]D0@$Z%A"-1B/V7>IHPZ'S_NXH4@00?D'$0E^*(=)"%@ Y R>>7$-,6
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MM83\E%E+'-LLB#!M=_])/:N4C5J1W?^A'<=A%V6WN,9VY L<"+@FW'!05^'
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M 7JO7[E9\\DLP:U679P.)(ND*D(BHYXN)F*$42#'*(^%U4I^Y$SR(%D49,X
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M^@=STQQA>N9P26E3+92+)A>K/ H5R:W+!^7-ST!\PJE,?UG[U@%WN,JO);+
M7*_(/&L9*E9*Y005?60+"F)V<H+"'FVY8V(5VY9G..9)44I)4&2)H:_)N.S%
M+ U*A=T34MN"MCWC#5NTC8QHQ=N[[*V(3S*.(PI8H;M(74;HVA5N,?^((?9X
M'[-B?E1_7=%#R0:_HD"Q['DKU0I^6[C@/.8M%S Y47D_':8:,*>UN2(!XMB&
M2>)E-CE!B8ISD]W7,2D*I?&3UI+H*MMA$S9KJ%:RJ$@.(\%9+'X"S,#IJ [C
M'?[><J=%I+)9/>"L$!MQNK]KV%'NWJ.M=<@=<RA67.,&?9ZC^[8L2]3+8A 6
MH4+;JPG5,<2,6Z$"M51MZBB*BJ@P%J56QFXOZJ9#;BD=6XXSM"2CV!9A_H7#
MQ%0O4T5)>%$A$-6J?$I-3K'G*+LJ+@-54E('D"AUFLB]X:NENT#7 KH?=/P+
M!:*.E?T9+?#H*N5F2!;#ST7&]+@IE3Y1J^.V[1A%1ZWJ)[4@S,_$G)4+[S"!
MV9_8K<L7H)T@9CD+L]ZSPFK.8F1;UO1PP%:S9K<MQ7+/F"@6:,<_^S71U=9-
M<A7(.2B5,$=]K+^HF;_8BC"V* ]SOMAJ>TQY:RII="#'.FL6H^AN#D, SN81
M-<<^*TJ[CHA'419I@.(R=9M4*9T:%M7*5&#DU1O>((=%8!I4(K8V_J.96Q(B
M <^B8,RVN<W(N.#-?9>W67!_ ]XYA=.82>WVWW7Q$6?%11O+8P$F^#JJ'&:M
M&#D"4#<G]8*0_L7=<DO&SNSW U+"L#.>":NPF3^AG!7,-6GHXXXI=Q Q.8S(
MF2H3:UTR:U!?-&.P %G03%WJXMZ1%%027BZ$DF>\80Q@TSWN\_J'R2)3V>V8
MVX[UXUGZSQI88"C&16DPH;H:YD-M#"N;C5H!7#B>3S+Q9%3UK][;LL!JK&:A
MO5K*//+>7!3M7XHEM4A0&U&O'5*C5 PATJ^=D9ZCF!=P\#"_!D[9R!Q,>)4I
MC1OU.CNNDV(MU3"::=DAXUBN@KN).Q39G6U;UU:PYJTQ[QZ'J8[BTG-38(R7
M*%<#9].;)& XDRM*QD_D_*4"+Z[P3#=,;?GR32RX!\[9I*-',R 2$LN,,,M4
MP6+ECM:@C-%@2]CIUN.0(VU5\!_YO!.B,C0TNX['RG%<YC%65_B4+W0L-C8;
M&\O."CI^< #Z9Y?^B5)>T?Q![V1^M^7."OJOM,W$I.-DF3CM+MVHYL[:.O7Z
MH(0,V,>R16[LES-ON=7;3Y7JL($\Q4=>/*MBIXR:IE1.9N %VD>9-^N-K65W
M97EC!>UNW!A.FX7$Z>H?%"EZK5E03D8R3^".@[&8#LO56?PHI9(A:% NS]9L
MB \WL.D"B72M-%[;EF793!AT4>1=D B4:#NX;:B*;>5)7CF\"U9<"DOF#1D9
M/NYB9VD=VJFC&)6E# 9/3<Z4%]DN%$_W!M?2F.[T&R^\_#='&FXO(@UG&FFX
MO8@T?(!(PQ<G1W!CES3H)EX6+U$DJ%ZL8LY1B\VHL,?],W-%*I"YLNR;R+Y.
MIZ'4XQ(>4:/H#>W@R15\X&:1EJL#HT1LG@'?KO%4^9;RM;QI7M6:($%<B>8X
MGRUGT&YU8O?R^@K_P"P"G00,C9YV]\?<57YAMG_.&Z9K,2E7))S,F]!H;M[0
M.<WHN\"39[QA4,..C/%.^9J-O)@9)42)DG8WHY]E0]0:7(E36RERO)"26)QI
MCOF;U#LQ5;LK:C468:U6RC4X6X'3W907<2HO8\-$5T>1-\1ZET6QXVXW@H42
MKEW2&U/PZ87G CK&(M<ILH,U3F6N R?7/5&=XI7 T8W0*@%7P+9M&EFGIEB_
M3^G.5G9PEA9(O>!]A>*+U-X%J@\H3?$N*(T"!E9RH>B0A7BQP"&J89:Y^4J-
MO>5^P%*;[X1MUS;\3D3EE07'2>TY^F&IX$YF77>:D("666HCK:RH6%L":VD4
MLXR*"1A:!&ENMI:'9N3#@.MEB1.,QTA17'-EUKQ9S5$:,&:"<:?/U%E=LT)R
M;=,Q>\R*;'#*@5*&=(>RO[&DT@"P4V8,*JNP/N'9Y3 ^)"5A?FRE"Q<JF^EJ
M2;')Y[;3Z<W'J@_W@H<]YPWGQ#53 N(.B,K%-SEB$JX.]QW/XQ&6N]#%$+BL
M!!?SBF0^XQ\O6$IN!5\;FQ I3<AH/K841^,("%UFQZ,BYIZIEM%+(XIG0@SW
MPZ"_2F'TNIQ%EPNFJM(0D^(B&:U2GYP'VI>@[TD_I.8)P+$':/+",NF!XN:6
M]"<NT#R^N#[/>,-G7/FP]):@K,>!0W>R)C&-#OI.'T,) MM?52S;GX^A9IM
M1 T?9&#BIITAEL##B 0TD;*73/>6Y)(I)OO(VL9"-IU_Y+Z?R.:/TG%5=/UI
M$J5=)("+4.;G@\9$LK(B<(I<D2$%&.DP9#,&9N/U>BP-U'+2O55(NZQ.E9?@
ML*I>4+XFD&&C^9])VRA6%3(U6%7QHY"3 *DJJR^O6/8=<V<@8[*A<0T]L[L&
MF08N*'<$8]'W,"P;Z7)-U>'RJ:@OZ3U29Q9:@WG3M1RU4.ZME-%657"TCA6I
M8W+F4MKTI2QD-:IJ8 Q6;OHC=?*W%%'HL[9AMZ#)AT)/F5@'EG4PG&'D<+5?
MHO(=U.!0,Z%4H2YW0_&P[!4(47:\7PV+BF'63EAZG#I<33.*@GS&9X(P7G")
M9[SA71TI75.E/@C]3-+:=+R]YM*01&X"_R]1'^Y1Z"46! E!RRCUC7B4<(;)
M7>:6UC@)S(Q?NAHV_5+/=]U"TK/[I97<Z;-KUJZT(TM/][G_ JGBSAB.=!7^
M@RD0FM$6?-B8HNCY\AKXT1Q:[\$N7F1G5,VD"@M#JI:U4(TEWTL0+P/7H75U
M<ADG*D==DK4%B5(N \4L@5)9%-5G6JFHC&7GT/'H,:T7 4(!LUU9FE%_?=A!
MKL2RRGT'R,1\>%Q%E,3EX,*+0F[,1<M"PA:R@N>F78('Q@ ;55>BEN:8L/G<
MI-1RBU1:$VN6.R95E!0)8/:JZ4:E>)12C?&PM$C.3W2 =L;C=$L+S8-*YG>4
M,<VJRE?*9</8A$(L'!*WCFG;6<2TS32F;6<1T_8 ,6TOI'K>"<C"5#GVQ(O/
MQ;$FU,]XTR].F+3"V8D1<TB>H&LU H%/KEZB6$)F8_2^ \^,$!DR1EG#/#=8
MLFH;FU)_$^:Z*!==,(NVFTUDA8^MD@-8[JKO!-Z_CE4L.3,=V]]@C *Q=VE9
MF0M?VP&*;-\;<*#YA+681$LON A]7JK1CHUHI'MPY20BM;0QM[\\EV.3.(22
M%!83CF.]\S*IALSRU.,E#T[=B:Q:R<7J<]B08Z=+T4%9]GS@,!>2K.0TI-;G
M58DNWB>NT</*U+:WRFR4BDWCMT8FH^8AU(Z&#XI\7UW)606J,YCJ4L/M1G0X
M",5ER, +;9D*\]%,5>BA0\$A/L]HE:2&Q>:Z>68%M$'AZ67-5LOB66L%M.&G
MHS31>(&3Y2HW=<>X7$Y:&;]X8>TY;]BRPZE.UY0ZQ<7*2GMKTWM1Z)ORW5WI
MII'V=BF:D<<@H9M&)59JD-+-$NX)93 ?6"M,Q\T>\O'<JN)[S:KW7M,UMC)T
M)D(84!L@2L''FO,N]Y)"765(W9 327O$&\H!6-9U9/55 85J%&8A7]E%SM5>
MH:*I88_3N#+:4\OG)@GCT)/8T(E7VXM 5KT,H_/%+7O&&_Z&AI1B[B+B/_K1
M$//S>?)CPZ>*?% QGEH)&\';J)NBYRI2%'J^5"N4HD=VWY)9N]Q2/&-)A24L
M\/09;Y@$WTG42J1#A?^*ID3+C%@FL&5-4K4P! 2/9 U#W%/?URW)(ZZMJ((L
M3/Q9M7)LN( L)NIP@9@ !#SC8R&NHB))E"%+1T5:-C83"Z6J:"&#8Z$^'R=B
MN)M*E><=JFYJ9O,3[7.+T#!RL3; @H0>VCT\E!\D&\A(ECKPF*K;ZAW W[P>
M53B 6AT95JI C.P8*_G**PSH5XZ03(>I91*AU;"NEA,MK7PI+36JUHLD5B_L
M>,]YPZ6Y263R[X7=E"YSX8)AO&#*V(A(3IVN; $.;X6\&E&3QLP/&R=R%-NW
MA9BC<RX#RQC-Z*Y$3Y;LS$@YQ4AK:Y:R29A;9*3JFM=%NR"SE24FVHX.W>R4
M<Q4YUD6B"9]=L2S4J0K3%GW+^BR9)98LAP9$3XKTD2Z01'DI81!%V0H+LZ(Q
M<QHJV><O*"QS<46?\8:Q2+PI!7%CK"1?B<E"IP;YN,D5!75QP=_B@ 7FB%B&
M3E8WQ R$!)A+%P9'!ID"4T9!%;DPFS*H,&C]NDAR6J.JDFU1DXD2H:(CDTNL
M#C3M$C&M,,NK6>D0AA&S$Y($'<LO:R_,P4K7EP,9Y,E#9#KUT@7W*,0MSJZ\
MIH&P5E/F1[DJCZ=6F%6=<&..%DERAKJA3"+3>I:;-K*;T0HTU6)%<4?\%9;&
MTP=SG75L-='56]EAR2%\0&+Q3:.\Q@/8_ZIN-%@2TKJ@.<_&\L]Y(<,TT%GO
M*BIY+ZM#N/!Z/!=,MDR!(')@,B.3 '/Z3.0F?/GBU(Z8H^@%5<"38P&DRQ9V
M&5/-ZTLO'J@4$36T(BY9&Q&0]BR+>6:^(!TQ(YK*[$9*C@N$,Z0RF9E&!&2?
M-58.[E!Q*>^L!,U:J4$/&,:K4!PY0?A558.K8:NL;KTF-EH;8M_PBW?^!?"(
M?7\8 P&&OX[^ E!NM-9JHGUV=O0Z%\Q3$[L4$)-]?:S#>) O3'E89(J4GG#)
MUMJRS=FT/:N>RG\MR/)SWG ;+7NYZZJ]4I+2RR;Z=(WP*3=)=D TB)S1P*34
MA""C9)G)TW!3&RGCT)<Z)XUJH]DEU;- 5@I^2L@4#T(4("_I9G #04SL2VT2
MLMH^M[FW#W]BDG50T%1;R(IJ.2Z%FL1D)5$!Q,2NJ!$&_."F7<H^4%55Z%8X
M"==6Q<ZJ08P[,^XW#0AUVR29@H8C?%O?-*8S4B['7)*--NAPO%.WP#1SI$>U
M!<)F*J,<W9GH/#8=]+2^(;:FC5/\R>/$C)%GA3P:R*%,B:0#_LB70D9R[$WV
M;RI9&7Q*F9A*([!X GZO0 $B[F$OE^W1*Y(IC9$8I,GE*$F*#D$[#KE?-SM6
M.9D>6]OB/RGZ.V,#2.]-D4I.H^?.*_IK\B 3S:SE7. L]8/X+ /.DN=8T<(:
M%=9;2H.$3Q(G4AV=F+M-4MIY(J_/FI3.6,(]H$^KE9-<&PI$E<,L  ))SJYR
MC7PD'_MG1#8BH/,F!2]XZ^PEXTAUU,3^Z25MK9#B*=/>E#1G'9@=US*)3%<B
MD<04NA@M&QBFJYK(995%LH9.U 6O+!Z<6:C5 YQ$9/;U44%E6+[A<1PJ,LK0
MF$M_ZO+<6?'/YG*OI.JG,BT@4,R09!&U_2RZT)MR,(91OF";:H^7!UO9WJ9
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M=S6-5K,\?!MF4;F(:>!CA53XV_=P=:J9IG1![S_+K<[:N;P:>1'9/D4!?#O
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MA"_<.B?0;9.&=_54A,H2DIW1BR)U-_C7UQ?^]=GZU]<7_O67Z%^?Y>:(I7,
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MKK)\'!L:*$7,"ORWA_,4Z-WN_;N>X/63W1+VY?/?\N/9%K'4/M <-_ZA=2V
M^HA O;\[<.]OSL5J%Y3KJ5VR4Y#](@^=D O2];2A.G_4X&FM=D&[GMHMH^*]
M/OK2%K1K =7YABKKB2^9&RSHZU/#V2^9;6]!"A9@G7.P[BN@+F ZWUSK<?C
M?9W5'D?3+)!%(TLLEO]G97$'%V"=<[!^QOBZ!4!GR7]U=M[\\(N9N?G04_X
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M.DF5O*6=N&W'=J=GYDL7)$$6IRE2X6);]]>_YP#@)E$V95,MF,9\F+@E$3P
M#IZSX"Q>_,O Q8:E'AVZMPZ\CU]5CBT'7F$1&V@G 0^J\^C,1?WA=G=G%GHS
MUZ>B&:A'_1D;W!7-K$TC<W]L+5/=OS[4;MR9-=0Z1K>NG6#?6=YP%F@>$)_?
M3.-H[%)A[WHX<6T,J$N:V3)"INX(3*'0CZZM1>]:WNQ67,N&<0'R*"Q/-#SE
M[4VQ?RU0@ U"1R,+AP>Z1T!^Z/NI@#BD3H0<^GXX%8$V(5"*W<OB'K?L+1CG
MM\=GD;DNQHOM[(MY@V(^<USWA:;,/HU#_SX1A]RRC6"8V/G@:T<)D3#R[DX?
M*)_[%KMY/HDW\-!U^+38ZZ^H']H!^\G%C/+Z>MJ>=HC=)7##^K!1P!8XC4O7
MAE6&Y=KC+9ES9B0"$=G(YRY,IR$ 6WQQ#:?!&L/ 3@#D+0^]]'Q[X7E\KXA=
M%-/6> /#Z$G1_YV$,$=&G,-NG@C^(X>)?=Z O7"$@^A+-XH"%(!-IG @]WZ7
MZ99^VVUAVZHM;'*35D9;V+9J"_L=VL)66UW T.4^P_D<6/ODU:.[U D99=IH
M1B&D(.U!5%*.UPA]3.O,!+^;/1.O/A\-=D>YY+B9-XAO1.#5./5X^M$W!;!5
MF1R+[GZ4Z]AEUTMXSM0+\)SFN+L[BN?>!L\UGT2ZZ*;D)7RGMQ36*;Y+\UWK
M*;Y+_.PO8;Q6\PG&V]WAB*<8[XTP7OLQQCL"QF->VI<PG='NU<QN2Z'=JV:Z
M34?O7SB[.W']*)9D9[1S$W<7$G-S(CH#D9""62$L@65"+&]*G$P215UCO02Y
M8S,9$Z!V=T>,<P_/BVQ5GK^/217<QS,C<^9/P&P+.K7V6)Z;/8=_ __:-O,.
MU;5T+C([4T:7.U8/TXX\9&<K""C5[ER1=&LY0P^SD'=W$N,J]M2A6RJTV8$;
MPT.8VROB1F/ZZFFC#.=G^RXNI!78_ 4>G'5,IB'LYWL4,'_@.B$[7N&,C6ER
M'85Y='=W(I<DS_U92@N*YR#3>=Q.PDF%)XQG=#FY/F)HE@CULBS[*-D\G6U?
MRSGB-3@8"^$'H"4MQ#+5%G/T\<69,$GTZM$A9I79<SZ/3&J\EG(68X;\9K+\
MNWJSUNEV5\BWZ,8@6N#5"?^[.TG&OU9JPO\Z^?Y\0:*$_PSI*Q/_Y<O[5\A1
M-G* 8F>-0(YP]LXD/3)M4(CHW,.N154C0$/,>Y@E6TYGMCNGF,P)LBUP/3_F
M4->A>UQHLY1(?C^SN[.D[LK$@)5FMI+ST_E@UNCG'\A776_^$*6EG]X<?]K=
M,<PZ7FM_OCJ]^;=V\>7\^.KZX^FE=G&B'1Y?W?1/S[6#X_/CD]/#T_Z9^%[K
MGQ]IG_KG_5^//QV?W[!_7AV?]6^.C[3KFXO#WS]>G!T=7\%/;F[@Y[)DPK^%
M @>;F>,U]WQ<W#L@YB;6#,7?(?4" @K& 77HV&(7O_Q[ID8D%^C57ADI=W\[
M]1!HX,?U!>"_4RZ"\F)6!@G+N&F66G9[,'6O#WJ<G914&<Q_?$-K_532?OIR
M?O'R?NU%R5RF+X0\%A\EYV(_)^IQ;:KTNEGZVO;:G5ZRN'DA@T7)+),NIOKS
M\B':-P>+C@_F6BB"QZ*C T8)?L,*=F")#TYYJX[UF):/4F:2.9&)W^D(J9.Q
MB9-A-F</;^9<".:.S9@5G+W][=D@K\NR(<MD57<#Y#X2J%:=LT)0QW$AJ M1
M"(I%?+Z-35*G1)V2'+I 6UJ2&\Q,7:Z:AC8'T3"'9U:70V>2R.RH\(2930LZ
M-X;'DMN<>X9%S1N@%HOQ\3R-)(-B0$1.@$=O0^[U]R. QNR16Q>.KQ,% T2W
MAM'M0.HMNSL9V]@'1L6T >HG%[.4YZ*DAJ\![PK# :@8X=712.2<D"6S&Y\C
MT<!SS<)12! ]/T'CV]O=$=<N=RZ[4)VY]]2K\;N=*%Z?7R*S;_!=>$F+Y<;@
M3W[8>$8'?UZ0&KV4E?RS'*R@RBZY5@X/>Q.-/[)\3(=A!WKQ+?P[*UU;.7J5
M3-[KK9S>)_(*.BJOH-R\@H[**UAQ1I2@>L&$CQ^&=!;L[A!,.QP!HP=)PM38
M=0,'X-?GGE80 8R]:OPR>0G_>>783#585O2583^<Z1BU455B_UZ$ZMV=1?\N
MJEI"9.1)3-2Y$N]6'+(#R !/^"BTAOLNG"7'_=,:>*YC/=2T4V=8KVDMLY6R
M;0[LNU%-.[:G/AR-46UWY_S?L#XMLU'7^CE.8W9%BB%Z9J?6ZW5JG5YC13Q!
M34M'?^(FP%^'VJ5'Q]3#R(WK5;_:W3E:_!F;;\YXQTL_3 7VL3""*#LR<IFO
M"'Z(M0]1K)?X&(D4%?-=X@J^N_%NUU@983])^UO:,I\!8*0[6[X?QC6#\1](
M_HH5XG&RI8V_M&)O7IQ_!T_G(R5[2W2"%BW>.\@O>/J];<F?!JP8, OE08(7
M[S\S=X&R&,"/>4:>+C7[LI6O1M%[W/80PV'XPA7]GSM>NAMFZUZ91;EF@JGB
MDSQ(B:V*3Q4Q;,0GQ:IB9R;[.@!-4K(4SA9DP<O8"U?QLQ:I$ )#65EZ^.0B
ME>03??BZSF*Y]QLO*JZU)16Q]0\1#??JU,%JD)5;N%Q*2A59%2!+L=OW!?Y5
M/9FWL0KGKD/KKV!OJD:6.G.*+,5NE85X277[5[-/52-+G3]%EF*WRL*]3!H]
M]G3.A(E&D=3*F:/.XFM<0$668C=YH;]$33\.7VDW_U'FXF0*Y93$9*G^G5(R
M5Q(*)#^%*SJ5ED>U8;1K;6P\*^_6LSZ];VS?Y:=PXYSYOZ]K2=^B/;'8SNE(
M71=43JLS3;/6-@SI5I"U.I:,)L5L+]5&ZN5H(F72](]7;CJ4N18YM3<5Z%?P
M')I-H]8JR2HH%?2;"O0KQVP*]"54[1=K*DNW0^K8O?38]?1:VVQ)MX*LF[AD
M-"EF4QA?:<5>5,>_XJW5I-LJ=?Y>JM#SQF/2K2!K_BX938K9%-A73Z%?;J\@
MW1ZI@_=2E.]UY$3YCD+YRC&;49?O4DBI],E:I%MI2;=1ZO2]&.I[M:Z,4-]5
M4%\Y9E-0+Z%"WP\]UR/:(?%]RP.E7KH=4L?NA93N57GM%%F*T]9:NS>NSG\B
MH,]KU\.)Y](15F.4?L.J1I8Z@XHLQ6D50WNI-'K;7J>-B_:NQ\GF-<=]97A7
M[J0:M5:G43/:9I774)$E$<>UZA(RVPI?SQMN6%65&OD2M] M/V>R?"I9]=S2
M064#'<5Y)6!.'_98Y[T^KE<V( /=A[4!X_U74 %::&&VJM5V9F3B^^&4LI%
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MPF 9=T7&*@=;P&!1.**X;HHH%I<3>;%^RNEXQ(^B]%/YV%UAHV*6XMA84G6
M;=CMO.#">G9[5']#0>-;Y'8%C8I9BD-C2;GTVU ;>7F"]: 1*U4HC^9;Y'0%
MBXI9BL-B2<GGVX#%153,]V:BFL@J.C"OHMDQU\=2\7P&3?.]B.M!JD)3^0^(
M0E/%+,71M*3\[FV@*4^97U/)9/43I%,SWV[H*TSY_^WM:2<62+\?M4MR2S_
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M,^WZI@^_.3Z_T:X//QX??3X[OJZKS?M^9+\C[W=W;E@EF"@1A3Y,K $:0FA
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MB7P?W9*4GD6?J*"*&*G>1]\(S]P1.6"<JJ@OTSFGAMHOBH;/HG='W1,2M=N
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M-C(N:'1M4$L! A0#%     @ AC*B5$W,;Q'% P  \!H   H
M ( !0'<  &5X,S$M,RYH=&U02P$"% ,4    " "&,J)4TCUCI_$#  !V(
M"@              @ $M>P  97@S,2TT+FAT;5!+ 0(4 Q0    ( (8RHE0V
M0.W&$*@  +WP!@ -              "  49_  !F;W)M,3 M:V$N:'1M4$L!
M A0#%     @ AC*B5*L1[! O P  MPL  !$              ( !@2<! &YA
M;W8M,C R,3$R,S$N>'-D4$L! A0#%     @ AC*B5 .+1M>'"P  ;8X  !4
M             ( !WRH! &YA;W8M,C R,3$R,S%?;&%B+GAM;%!+ 0(4 Q0
M   ( (8RHE0[B]W1I@<  %!=   5              "  9DV 0!N86]V+3(P
D,C$Q,C,Q7W!R92YX;6Q02P4&      @ " #B 0  <CX!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
